HK40000186A

HK40000186A - Systems and methods for cosmetic ultrasound treatment of skin

Info

Publication number: HK40000186A
Application number: HK19123451.7A
Authority: HK
Inventors: C·D·艾姆利; 徐道中
Original assignee: 奥赛拉公司
Priority date: 2016-08-16
Filing date: 2017-08-14
Publication date: 2020-01-31

Description

System and method for cosmetic ultrasound treatment of skin

Cross Reference to Related Applications

The present application claims the benefit of priority from U.S. provisional application No.62/375607 filed 2016, 16, 4, 2017, 62/482476, 4, 6, 2017, 62/482440 filed 4, 6, 2017, and 62/520055 filed 6, 15, 2017, each of which is incorporated herein by reference in its entirety. Any and all priority claims identified in the application data sheet, or any amendments thereto, are hereby incorporated by reference under 37CFR 1.57.

Technical Field

Several embodiments of the present invention relate to energy-based non-invasive treatments for obtaining aesthetic and/or cosmetic enhancement effects on the skin and/or tissue close to the skin of a human face, head, neck and/or body.

Background

Some cosmetic procedures involve invasive procedures that may require invasive surgery. Patients not only have to endure several weeks of recovery time, but frequently also need to undergo a risky anesthetic process. Noninvasive energy-based treatment devices and methods are available, but may have various drawbacks with respect to efficiency and effectiveness. Some cosmetic procedures produce a sequential series of treatment points or lines. In these procedures, the time period for treatment is the sum of the sequential treatments.

Disclosure of Invention

In several embodiments, systems and methods are provided that successfully achieve aesthetic effects by splitting ultrasound therapy beams into two, three, four, or more simultaneous focal zones for performing various therapeutic and/or imaging procedures, using targeted and precise ultrasound to cause visible and effective cosmetic results. In various embodiments, the ultrasound system is configured to focus ultrasound to produce local mechanical motion within tissues and cells for the purpose of either producing local heating for tissue coagulation or mechanical cell membrane disruption intended for non-invasive aesthetic use. In various implementations, the ultrasound system is configured to lift an eyebrow (e.g., an eyebrow). In various embodiments, the ultrasound system is configured to lift loose tissue, such as submental (submental) and neck tissue. In various embodiments, the ultrasound system is configured to improve striations and wrinkling of the low neck exposed shoulder. In various embodiments, the ultrasound system is configured to reduce fat. In various embodiments, the ultrasound system is configured to reduce the occurrence of cellulite.

In various embodiments, the ultrasound system is configured to image to visualize tissue (e.g., the dermal and subdermal layers of tissue) to ensure proper coupling of the transducer to the skin. In various embodiments, the ultrasound system is configured to image to visualize tissue (e.g., the dermal and subdermal layers of tissue) to confirm treatment at an appropriate depth so as to avoid particular tissue (e.g., bone).

In various embodiments, treating tissue, such as skin tissue, with multiple beams provides one or more advantages, such as, for example, reduced treatment time, creation of unique heating patterns, use of multiple channels for greater power, options to treat the skin at two or more depths with the same or different power levels (e.g., a thermal freezing point in the superficial muscularis aponeurosis system ("SMAS") and another defocused energy at the skin surface, or other combinations), optional simultaneous treatments of different depths (e.g., depths such as thermal freezing points at the same time or 3mm and 4.5mm below the skin surface in overlapping time periods), and/or treatments with one, two or more simultaneous linear or line foci (such as different depths or separations below the skin surface). In some embodiments, simultaneous multifocal therapy uses flutter.

In several embodiments, systems and methods are provided that successfully improve the effectiveness and/or efficiency of aesthetic effects by using targeted and precise ultrasound via a thermal path to induce visible and effective cosmetic results. In some embodiments, a single focal zone is targeted. In some embodiments, the ultrasound therapy beam is split into two, three, four, or more simultaneous focal zones for performing various therapeutic and/or imaging procedures. In particular, embodiments of the present invention improve the effectiveness and/or efficiency of confirming a proper coupling between a treatment device and tissue treated in a treatment zone.

In several embodiments, systems and methods are provided that successfully improve the effectiveness and/or efficiency of aesthetic effects by splitting the ultrasound therapy beam into two, three, four, or more simultaneous focal zones for performing various therapeutic and/or imaging procedures, using targeted and precise ultrasound to cause visible and effective cosmetic results.

According to one embodiment, the ultrasound treatment system generates two or more simultaneous therapeutic treatment points and/or focal zones under the skin surface for cosmetic treatment, wherein the treatment points are amplified by the fluttering ultrasound beam. In one embodiment, the focal zone is a spot. In one embodiment, the focal zone is a line. In one embodiment, the focal zone is planar. In one embodiment, the focal zone is a three-dimensional volume or shape. The fluttering of the ultrasound beam focus enlarges the treatment area by dithering, blurring or splattering the image pigment by means of an air brush towards the focus or focal zone (e.g., focus, line, plane or volume) by mechanically and/or electronically diffusing the position of the focus by changing the frequency of the ultrasound treatment beam and thus changing the focus. In some embodiments, the dithering increases the effectiveness by creating a larger treatment spot and/or focal zone. In some embodiments, because the temperature of the hot spot is spread over a larger volume of tissue, the flutter reduces pain, which allows for potential reduction of dose. In some embodiments, mechanical dithering is one method of diffusing the acoustic energy from the ultrasound beam, and thus, there is less reliance on conduction of heat away from the focal point. In one embodiment of mechanical flutter, the therapy transducer is moved locally around the expected center of the hot freezing point (TCP). The beam movement may be side-by-side, up and down and/or angular. In one embodiment of mechanical flutter, the movement of the motion mechanism is fast enough to produce a flatter temperature profile around the intended TCP, which allows for a reduction in total acoustic energy for the same affected tissue volume or allows for the same total acoustic energy for a more affected tissue volume or any combination thereof.

According to various embodiments, the frequency modulation modifies the position of the focal zones and/or the spacing between the focal zones such that the electronic dithering of the beam via the frequency modulation precisely changes and/or moves the position of the beam focus. For example, in one embodiment, a small frequency swing may be used to dither at +/-0.1mm intervals of 1.5 mm. In various embodiments, the frequency swing may be used at any one or more of +/-0.01, 0.05, 0.1, 0.12, 0.15, 0.20, 0.25, 0.30mm dither 0.5, 0.75, 1.0, 1.2, 1.5, 2.0mm intervals. In various embodiments, the frequency may be modulated by 1% to 200% (e.g., 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 100%, 120%, 150%, 180%, 200%, and any range within).

Several embodiments relate to devices, systems, and methods for providing one or more (e.g., multiple or many) focal zones and/or ultrasound treatment points while performing various ultrasound treatment and/or imaging procedures quickly, safely, efficiently, and effectively. In some embodiments, imaging is not used. Some embodiments relate to splitting an ultrasound therapy beam into two, three, four, or more focal zones from a single ultrasound transducer and/or a single ultrasound transducing element. In some embodiments, the plurality of ultrasound beams are electronically steered with frequency modulation. In some embodiments, multiple and/or segmented ultrasound beam apertures are used with frequency modulated dithering (e.g., electronic dithering) to provide therapeutic zones or points in multiple locations. In some embodiments, the dithering involves deliberate movement of the position/location of the focal point of the energy beam. For example, in one embodiment, dithering involves dithering, moving, vibrating, changing the location and/or position of a single focal zone, and/or the relative spacing between two or more focal zones. In various embodiments, the relative position of the focal bands is dithered by 1% to 50% (e.g., 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, and any range within, such as a percentage of mean positions that differ by a certain percentage). In various embodiments, the spacing between the focal bands is dithered in a range between 1% and 50% (e.g., 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, and any range within). In some embodiments, the dither may be achieved by mechanical means, electronic means, or a combination of mechanical and electronic means, depending on the system design. In one embodiment of mechanical flutter, the ultrasound beam is moved locally around the intended TCP center by means of mechanical translation or tilting of the treatment transducer or the patient, or any combination thereof. The mechanical translation and/or tilting enables the acoustic energy to be diffused such that the thermal conductivity limits of the tissue are overcome. This produces a flatter temperature profile in the tissue when compared to a stationary ultrasound therapy device to reduce or increase the total acoustic energy producing the same affected tissue volume. In various embodiments of electronic dithering, a frequency, phase, amplitude or time based technique is used in conjunction with a uniquely defined transducer to move the ultrasound beam in the tissue without any mechanical movement. In one embodiment, the electronic movement of the ultrasound beam occurs significantly faster than the mechanical movement to overcome the thermal conductivity limitations of the tissue. In various embodiments, the ratio of relative focal band positioning via dithering is 1:1000, 1:500, 1:200, 1:100, 1:50, 1:25, 1:10, 1:2, or any ratio between 1:1000 and 1: 1. In various embodiments, the ratio of the spacing between relative focal zone locations via dithering is 1:1000, 1:500, 1:200, 1:100, 1:50, 1:25, 1:10, 1:2, or any ratio between 1:1000 and 1: 1. For example, in some embodiments, the focal zone is activated at "1" and the open interval ratio of untreated tissue is provided at a second numerical ratio. For example, in one embodiment, the dither spacing is, for example, 1mm, and the dither distance is 0.1mm, thus the ratio is 1: 10. In various embodiments, the ratio of the spacing between focal zones via dithering is 1:1000, 1:500, 1:200, 1:100, 1:50, 1:25, 1:10, 1:2, or any ratio between 1:1000 and 1: 1. In some embodiments, the dithering is simultaneous with the spacing of the focal zones. In some embodiments, treatment sites and/or bands are formed simultaneously in the tissue. In various embodiments, the oscillations used to perform various therapeutic and/or imaging procedures are modulated and/or manipulated with controlled variations in frequency. Some embodiments relate to splitting the ultrasound therapy beam into two, three, four, or more focal zones for performing various therapies by means of, for example, dithering, polarization, phasing, and/or modulation techniques and/or imaging procedures.

In several embodiments disclosed herein, the non-invasive ultrasound system is adapted for use in achieving one or more of the following beneficial aesthetic and/or cosmetic improvements: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair (e.g., cheekback, treatment of infraorbital laxity), wrinkle removal, fat reduction (e.g., treatment of fat and/or cellulite), cellulite (may be referred to as female lipodystrophy) treatment (e.g., female lipodystrophy that is dimpled or not), low neck-to-shoulder improvement (e.g., upper chest), hip lifting (e.g., tight buttocks), skin tightening (e.g., treatment of laxity to cause tightening on the face or body (such as face, neck, chest, arms, thighs, abdomen, buttocks, etc.), scar reduction, burn treatment, tattoo removal, vein reduction, treatment of sweat glands, treatment of hyperhidrosis, freckle removal, acne treatment, pimple reduction. Several embodiments of the invention are particularly advantageous in that they include one, several or all of the following benefits: faster treatment time, (ii) less pain during treatment, (iii) less pain after treatment, (iv) shorter recovery time, (v) more efficient treatment, (vi) higher customer satisfaction, (vii) less energy to complete treatment, and/or (viii) larger treatment area achieved by the focused region of the flutter.

According to various embodiments, cosmetic ultrasound therapy systems and/or methods may non-invasively generate single or multiple oscillating cosmetic treatment zones and/or hot spots, where ultrasound is focused in one or more locations in a treatment region in tissue below the skin surface and moved via changes in frequency (e.g., via frequency modulation). Some systems and methods provide cosmetic treatment at different locations in tissue, such as different depths, heights, widths, and/or locations. In one embodiment, the methods and systems include a multi-depth/height/width transducer system configured to provide ultrasound therapy to one or more regions of interest (such as between at least one depth of a treatment region of interest, a superficial region of interest, and/or a subcutaneous region of interest). In one embodiment, the methods and systems include a transducer system configured to provide ultrasound therapy to more than one region of interest, such as between at least two points in various locations (e.g., fixed or variable depth, height, width, and/or orientation, etc.) in a region of interest in tissue. Some embodiments may divide the beam into two, three, four, or more focal points (e.g., multiple focal points) that are used for imaging of a cosmetic treatment zone and/or a region of interest in tissue. The location of the focal spot and/or the flutter may be axially, laterally, or otherwise located within the tissue. Some embodiments may be configured for spatial control, such as by positioning and/or dithering of the focal point, changing the distance from the transducer to the reflective surface, and/or changing the angle at which energy is focused or defocused to the region of interest, and/or for temporal control, such as by controlling changes in the frequency, drive amplitude, and/or timing of the transducer. In some embodiments, the positioning and/or dithering of the multiple therapeutic zones or foci is achieved by polarization, phase polarization, biphasic polarization, and/or multidirectional polarization. In some embodiments, the positioning of the multiple therapy zones or foci is achieved by phasing (such as electrically phasing, in one embodiment). Thus, changes in the position of the treatment region, the number, shape, size and/or volume of treatment zones or lesions in the region of interest, and the thermal state can be dynamically controlled over time.

According to various embodiments, cosmetic ultrasound therapy systems and/or methods may use one or more of frequency modulation, phase modulation, polarization, nonlinear acoustics, and/or Fourier (Fourier) transforms to generate any spatial periodic pattern with one or more ultrasound portions to generate a plurality of cosmetic therapy zones. In one embodiment, the system uses ceramic-level polarization for simultaneous or sequential administration of single or multiple therapeutic bands. In one embodiment, the polarization mode is a function of depth of focus and frequency, and the use of an odd or even function. In one embodiment, a polarization mode that may be a combination of odd or even functions is applied and is based on depth of focus and/or frequency. In one embodiment, the processing may be used in two or more dimensions to generate an arbitrary spatial periodic pattern. In one embodiment, the ultrasound beam is split axially and laterally to significantly reduce treatment time through the use of nonlinear optics and fourier transforms. In one embodiment, modulation from the system and amplitude modulation from the ceramic or transducer may be used to place multiple therapy zones in the tissue, either sequentially or simultaneously.

In one embodiment, an aesthetic imaging and therapy system includes an ultrasound probe including an ultrasound transducer configured to apply ultrasound therapy to tissue at a plurality of locations at a depth of focus via electronic dithering with a plurality of energy beam apertures that are frequency modulated. In one embodiment, the system includes a control module coupled to the ultrasound probe for controlling the ultrasound transducer.

In one embodiment, the system includes a vibrator configured to set a variable spacing between a plurality of individual cosmetic treatment zones. In one embodiment, the sequence of individual cosmetic treatment zones has a treatment interval in the range of from about 0.01mm to about 25mm (e.g., 1mm, 1.5mm, 2mm, 2.5mm, 3mm, 5mm, 10mm, 20mm, and any range of values within), the interval varying from 1% to 50% (e.g., 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, and any range within). In one embodiment, the sequence of individual cosmetic treatment zones has a treatment interval in the range of from about 0.01mm to about 100mm (e.g., 1mm, 1.5mm, 2mm, 2.5mm, 3mm, 5mm, 10mm, 20mm, 25mm, 30mm, 35mm, 40mm, 45mm, 50mm, 60mm, 70mm, 80mm, 90mm, and 100mm, and any range of values within), the interval fluttering changing by 1% to 50% (e.g., 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, and any range within).

In one embodiment, the system further comprises a motion mechanism configured to be programmed to set a constant or variable interval between the plurality of individual cosmetic treatment zones. In one embodiment, the sequence of individual cosmetic treatment zones has a treatment interval within a range from about 0.01mm to about 25mm (e.g., 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 19mm or any range or value within). In one embodiment, the sequence of individual cosmetic treatment zones has a treatment interval within a range from about 0.01mm to about 100mm (e.g., 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 50, 100mm or any range or value within). In one embodiment, the treatment tape is disposed along a distance of about 25 mm. In one embodiment, the treatment tape is disposed along a distance of about 50 mm. In various embodiments, the treatment tape is disposed along a distance of about 5mm to 100mm (e.g., 10mm, 20mm, 25mm, 35mm, 50mm, 75mm, 100mm, or any amount or range therein). In various embodiments, the therapeutic band is disposed along a linear and/or curved distance.

For example, in some non-limiting embodiments, the transducer may be configured for use with any depth anywhere and within the range of 0.5mm, 1.0mm, 1.5mm, 2mm, 3mm, 4.5mm, 6mm, less than 3mm, between 0.5mm and 5mm, between 1.5mm and 4.5mm, more than 6mm, and 0.1mm to 3mm, 0.1mm to 4.5mm, 0.1mm to 25mm, 0.1mm to 100mm (e.g., 6mm, 10mm, 13mm, 15 mm). In several embodiments, the tissue is treated at a depth below the skin surface, and the skin surface is not damaged. In contrast, the therapeutic effect achieved at a depth below the skin surface causes a favorable cosmetic appearance of the skin surface. In other embodiments, the skin surface is treated with ultrasound (e.g., at a depth of less than 0.5 mm).

One benefit of the motion mechanism is that it may provide for more efficient, accurate, and precise use of the ultrasound transducer for imaging and/or therapeutic purposes. One advantage of this type of motion mechanism over conventional fixed arrays of multiple transducers fixed in a space in a housing is that the fixed arrays are spaced apart by a fixed distance. In one embodiment, the transducer module is configured to provide an acoustic power of ultrasound therapy in a range between about 1W to about 100W (e.g., 3-30W, 7-30W, 21-33W) and a frequency of about 1MHz to about 10MHz to thermally heat tissue to cause coagulation. In one embodiment, the transducer module is configured to provide an ultrasonic therapeutic acoustic power having a peak or average energy in a range between about 1W to about 500W (e.g., 3-30W, 7-30W, 21-33W, 100W, 220W or more) and a frequency of about 1MHz to about 10MHz to thermally heat tissue to cause coagulation. In some embodiments, transient energy is delivered. In some embodiments, the average energy is delivered. In one embodiment, the acoustic power may be in the range of from 1W to 100W at a frequency range of from about 1MHz to about 12MHz (e.g., 1MHz, 3MHz, 4MHz, 4.5MHz, 7MHz, 10MHz, 2-12MHz), or from about 10W to about 50W at a frequency range of from about 3MHz to about 8MHz (e.g., 3MHz, 4MHz, 4.5MHz, 7 MHz). In one embodiment, the acoustic power may be in the range of from 1W to 500W at a frequency range of from about 1MHz to about 12MHz (e.g., 1MHz, 4MHz, 7MHz, 10MHz, 2-12MHz), or from about 10W to about 220W at a frequency range of from about 3MHz to about 8MHz or 3MHz to 10 MHz. In one embodiment, the acoustic power and frequency is about 40W at about 4.3MHz and about 30W at about 7.5 MHz. The acoustic energy generated by the acoustic power may be between about 0.01 joules ("J") to about 10J or about 2J to about 5J. The acoustic energy generated by the acoustic power may be between about 0.01J to about 60000J (e.g., via bulk heating for plastomerics, submental fat, abdominal and/or flank, arm, inner thigh, outer thigh, hip, abdominal laxity, cellulite), about 10J, orBetween about 2J and about 5J. In one embodiment, the sonic energy is in a range of less than about 3J. In various embodiments, the treatment power is 1kW/cm²To 100kW/cm²、15kW/cm²To 75kW/cm²、1kW/cm²To 5kW/cm²、500W/cm²To 10kW/cm²、3kW/cm²To 10kW/cm²、15kW/cm²To 50kW/cm²、20kW/cm²To 40kW/cm²And/or 15kW/cm²To 35kW/cm²。

In various embodiments, an ultrasound therapy system for dithering multiple simultaneous focal points from an ultrasound transducer includes an ultrasound probe and a control module coupled to the ultrasound probe for controlling the ultrasound transducer. The ultrasound probe includes an ultrasound transducer having a single transducing element adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations of a focal depth. The ultrasonic transducer is polarized with at least a first polarization configuration and a second polarization configuration. The control module modifies the spacing between the spaced locations via dithering of the first and second focal bands such that the dithering via frequency modulation precisely moves the position of the beam focus at the spaced locations.

In one embodiment, the plurality of locations are positioned within the cosmetic treatment band in a linear sequence, wherein the spaced locations are separated by an interval that oscillates via the frequency oscillation. In one embodiment, the first set of locations is positioned within a first cosmetic treatment band and the second set of locations is positioned within a second cosmetic treatment band, the first band being different from the second band. In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity at a plurality of amplitudes, wherein the first amplitude is different from the second amplitude. In one embodiment, at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more amplitudes of acoustic intensity, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezoelectric body varies over time. In one embodiment, the ultrasound transducer comprises a piezoelectric material, and the plurality of portions of the ultrasound transducer are adapted to produce a plurality of corresponding changes in the piezoelectric material in response to an electric field applied to the ultrasound transducer. In one embodiment, the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material. In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy via phase shifting, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity in a plurality of phases, wherein the first phase is different from the second phase. In one embodiment, the plurality of phases comprises discrete phase values. In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensities of a plurality of amplitudes, wherein the first amplitude is different from the second amplitude, and to apply ultrasound therapy, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensities of a plurality of phases, wherein the first phase is different from the second phase. In various embodiments, the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair (e.g., cheekback, treatment of infraorbital laxity), wrinkle removal, low neck-to-shoulder improvement, hip lifting, scar reduction, burn treatment, skin tightening (e.g., abdominal laxity treatment or treatment of laxity in other locations), blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, and cellulite treatment. Skin tightening by reducing skin laxity is achieved in some embodiments as treating a subject with excess or loose skin back weight loss, whether such weight loss occurs naturally or is performed surgically.

In various embodiments, an ultrasound therapy system for use in cosmetic therapy for dithering multiple simultaneous focal points from an ultrasound transducer includes: an ultrasound probe, comprising: a control module adapted to modify a spacing between the first focal zone and the second focal zone via dithering; a switch operable to control an ultrasound therapy function for providing ultrasound therapy; a motion mechanism adapted to direct ultrasound therapy in at least one pair of simultaneous sequences of independent thermal cosmetic treatment zones; and a transducer module adapted to apply ultrasound therapy. The transducer module is suitable for both ultrasound imaging and ultrasound therapy. The transducer module is adapted to be coupled to an ultrasound probe. The transducer module includes an ultrasound transducer adapted to apply ultrasound therapy to tissue at a plurality of locations at a focal depth. The transducer module is adapted to be operatively coupled to at least one of the switch and the motion mechanism. The control module includes a processor and a display for controlling the transducer module.

In one embodiment, the transducer module is adapted to apply ultrasound therapy using amplitude modulation, whereby portions of the transducer module are adapted to transmit ultrasound therapy at acoustic intensities of a plurality of amplitudes, wherein the first amplitude is different from the second amplitude. In one embodiment, the transducer module is adapted to apply ultrasound therapy, whereby the plurality of portions of the transducer module are adapted to transmit ultrasound therapy of acoustic intensity in a plurality of phases, wherein the first phase is different from the second phase.

In various embodiments, an ultrasound therapy system for fluttering multifocal therapy includes a module that includes an ultrasound transducer. The ultrasound transducer is adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations in the tissue, wherein the module modifies the spacing between the plurality of spaced apart locations via the dithering of the first focal zone and the second focal zone such that the dithering via frequency modulation precisely moves the location of the beam focus at the plurality of spaced apart locations, wherein the module further comprises a joint guide designed for removable coupling to the hand wand to provide electronic communication and power between the module and the hand wand.

In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity at a plurality of amplitudes, wherein the first amplitude is different from the second amplitude. In one embodiment, the ultrasound transducer is adapted for applying ultrasound therapy, whereby the portions of the ultrasound transducer are adapted for ultrasound therapy emitting acoustic intensities of a plurality of phases, wherein the first phase is different from the second phase. In one embodiment, the ultrasound transducer comprises a piezoelectric material, and the plurality of portions of the ultrasound transducer are adapted to produce a plurality of corresponding changes in the piezoelectric material in response to an electric field applied to the ultrasound transducer. In one embodiment, at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more amplitudes of acoustic intensity, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the ultrasound transducer remains constant over time. In one embodiment, the ultrasound treatment is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair (e.g., cheekback, treatment of infraorbital laxity), wrinkle removal, low neck-to-shoulder improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening (e.g., abdominal laxity treatment or tightening of skin on other areas of the body and face, such as any excess skin or tissue, such as during or after weight loss, such as, for example, abdomen, buttocks, thighs, arms, and other areas), vein removal, vein reduction, treatment of sweat glands, treatment of hyperhidrosis, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

In various embodiments, a method of dithering a simultaneously focused ultrasound therapy beam includes the steps of: providing an ultrasound probe comprising an ultrasound transducer comprising a single transducing element adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations of a focal depth, and a control module coupled to the ultrasound probe for controlling the ultrasound transducer; and dithering a separation between the spaced locations of the first focal zone and the second focal zone via modulation of the frequency to move a position of the ultrasound focus at the spaced locations.

In one embodiment, the method comprises the steps of: the first focal zone is imaged with an ultrasound imaging element. In one embodiment, the method comprises the steps of: the second focal zone is imaged with an ultrasound imaging element. In one embodiment, the separation between the first focal zone and the second focal zone is dithered in a range between 1% and 50%. In one embodiment, the separation between the first and second focal zones is 1.5mm and differs by 0.1 mm. In one embodiment, the frequency modulation is in a range between 1% and 50%. In one embodiment, the ultrasound treatment is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair (e.g., cheekback, treatment of infraorbital laxity), wrinkle removal, low neck-to-shoulder improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening (e.g., treatment of laxity on the face and body (such as abdominal laxity treatment), tightening of skin on the body and other areas of the face, such as any excess skin or tissue, such as during or after weight loss, such as, for example, abdomen, buttocks, thighs, arms, and other areas), vein removal, vein reduction, treatment of sweat glands, treatment of hyperhidrosis, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

In various embodiments, a method of dithering a focused ultrasound beam includes the steps of: providing an ultrasound probe comprising a single transducing element adapted to apply ultrasound therapy to tissue at a focal zone of a focal depth and a control module coupled to the ultrasound probe for controlling the single transducing element; and varying the size of the focal zone at the tissue via frequency modulation of the dithered focal zone.

In one embodiment, the relative position of the focal zones flutters in a range between 1% and 50%. In one embodiment, the second focal zone is simultaneously emitted from a single transducer element. In one embodiment, the method comprises the steps of: the focal zone is imaged with an ultrasound imaging element. In one embodiment, the frequency modulation is in a range between 1% and 50%.

In several embodiments described herein, the procedure is cosmetic in its entirety, not a medical act. For example, in one embodiment, the methods described herein need not be performed by a physician, but rather at a casual fitness center or other aesthetic facility. In some embodiments, the system may be used for non-invasive cosmetic treatment of the skin.

In some embodiments, simultaneous multifocal therapy uses multichannel signal mixing. In several embodiments, the therapy system uses multiple therapy channels to enable electronic focusing and/or steering. For example, a treatment system that uses multiple treatment channels to enable electronic focusing and/or steering allows faster electronic dithering to produce more thermal coagulation using the same amount of energy as other treatment devices, or to produce equal thermal coagulation using electronic dithering with less energy than other treatment devices.

In various embodiments, an ultrasound therapy system configured to generate multiple simultaneous focal points from an ultrasound transducer includes: an ultrasound probe comprising an ultrasound transducer having a plurality of transducing elements adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations, wherein each transducing element comprises a channel of the ultrasound probe having a geometric focus; wherein the ultrasound probe has a first electron focus; and wherein the ultrasound probe has a second electron focus; a control module coupled to the ultrasound probe for controlling the ultrasound transducer, wherein the control module modifies the spacing between the spaced locations via dithering of the first and second focal bands such that the dithering via the excitation function moves the position of the beam focus at the spaced locations.

In one embodiment, the plurality of locations are positioned within the cosmetic treatment band in a linear sequence, wherein the spaced locations are separated. In one embodiment, the first set of locations is positioned within a first cosmetic treatment band and the second set of locations is positioned within a second cosmetic treatment band, the first band being different from the second band. In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy, whereby the portions of the ultrasound transducer are adapted to emit ultrasound therapy of acoustic intensity at a plurality of amplitudes, wherein the first amplitude is different from the second amplitude. In one embodiment, at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more amplitudes of acoustic intensity, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezoelectric body varies over time. In one embodiment, the ultrasound transducer comprises a piezoelectric material, and the plurality of portions of the ultrasound transducer are adapted to produce a plurality of corresponding changes in the piezoelectric material in response to an electric field applied to the ultrasound transducer. In one embodiment, the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material. In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy via phase shifting, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity in a plurality of phases, wherein the first phase is different from the second phase. In one embodiment, the plurality of phases comprises discrete phase values. In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy at a plurality of amplitudes of acoustic intensity, wherein the first amplitude is different from the second amplitude; and applying ultrasound therapy, whereby portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity in a plurality of phases, wherein the first phase is different from the second phase.

In various embodiments, the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair (e.g., cheekback, treatment of infraorbital laxity), wrinkle removal, low neck-to-shoulder improvement, hip lifting, scar reduction, burn treatment, skin tightening (e.g., abdominal, thigh, hip, arm, neck, or other laxity treatment), blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, and cellulite treatment.

In various embodiments, an ultrasound therapy system for use in cosmetic therapy for forming multiple simultaneous focal zones from an ultrasound transducer, the system comprising: an ultrasound probe, comprising: a control module adapted to modify a spacing between the first focal zone and the second focal zone; a switch operable to control an ultrasound therapy function for providing ultrasound therapy; a motion mechanism adapted to direct ultrasound therapy in at least one pair of simultaneous sequences of independent thermal cosmetic treatment zones; and a transducer module adapted to apply ultrasound therapy, wherein the transducer module is adapted to ultrasound imaging and/or ultrasound therapy, wherein the transducer module is adapted to be coupled to an ultrasound probe, wherein the transducer module comprises an ultrasound transducer adapted to simultaneously apply ultrasound therapy to tissue at a plurality of locations, wherein the transducer module is adapted to be operatively coupled to at least one of a switch and a motion mechanism; and wherein the control module comprises a processor and a display for controlling the transducer module.

In one embodiment, the transducer module is adapted to apply ultrasound therapy, whereby the plurality of portions of the transducer module are adapted to transmit ultrasound therapy at a plurality of amplitudes of acoustic intensity, wherein the first amplitude is different from the second amplitude. In one embodiment, the transducer module is adapted to apply ultrasound therapy, whereby the portions of the transducer module are adapted to emit ultrasound therapy at a plurality of acoustic intensities. In various embodiments, an ultrasound therapy system for generating a multifocal therapy using multichannel signal mixing includes: a module comprising an ultrasound transducer, wherein the ultrasound transducer is adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations in the tissue, wherein the module modifies a spacing between the plurality of spaced apart locations between the first focal zone and the second focal zone such that the multi-channel signal mixing precisely moves a position of the beam focus at the plurality of spaced apart locations, wherein the module further comprises a joint guide designed for removable coupling to the hand wand to provide electronic communication and power between the module and the hand wand. In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy, whereby the portions of the ultrasound transducer are adapted to emit ultrasound therapy of acoustic intensity at a plurality of amplitudes, wherein the first amplitude is different from the second amplitude. In one embodiment, the ultrasound transducer is adapted for applying ultrasound therapy, whereby the portions of the ultrasound transducer are adapted for ultrasound therapy emitting acoustic intensities of a plurality of phases, wherein the first phase is different from the second phase. In one embodiment, the ultrasound transducer comprises a piezoelectric material, and the plurality of portions of the ultrasound transducer are adapted to produce a plurality of corresponding changes in the piezoelectric material in response to an electric field applied to the ultrasound transducer. In one embodiment, at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more amplitudes of acoustic intensity, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the ultrasound transducer remains constant over time. In one embodiment, the ultrasound treatment is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair (e.g., cheekback, treatment of infraorbital laxity), wrinkle removal, low neck-to-shoulder improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening (e.g., laxity treatment, tissue tightening treatment, abdominal tightening treatment, and any tightening of the skin on other areas of the body and face, such as any excess skin or tissue, such as during or after weight loss, such as, for example, abdomen, buttocks, thighs, arms, and other areas), vein removal, vein reduction, treatment of sweat glands, treatment of hyperhidrosis, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment. In various embodiments, a method of generating simultaneously focused ultrasound therapy beams using multi-channel signal mixing includes the steps of: providing an ultrasound probe including an ultrasound transducer including a plurality of transducing elements adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations at a plurality of focal depths and a control module coupled to the ultrasound probe for controlling the ultrasound transducer; and modifying a separation between the spaced apart locations of the first focal zone and the second focal zone via multi-channel signal mixing to move a position of the ultrasound focus at the spaced apart locations. In one embodiment, the method comprises the steps of: the first focal zone is imaged with an ultrasound imaging element. In one embodiment, the method comprises the steps of: the second focal zone is imaged with an ultrasound imaging element. In one embodiment, the separation between the first focal zone and the second focal zone varies in a range between 1% and 50%. In one embodiment, the separation between the first and second focal zones is 1.5mm and differs by 0.1 mm. In one embodiment, the spacing between the electron foci is in a range between 10% and 50% of the nominal distance between the electron foci. In one embodiment, the ultrasound treatment is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck-to-shoulder improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening (e.g., tightening of human upper tissues or abdominal relaxation treatment), vein removal, vein reduction, treatment of sweat glands, hyperhidrosis treatment, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

In various embodiments, a method of generating simultaneously focused ultrasound beams comprises the steps of: providing an ultrasound probe comprising an array of transducing elements adapted to apply ultrasound therapy to tissue at a focal zone at a plurality of focal points and a control module coupled to the ultrasound probe for controlling the array of transducing elements; and moving the focal zone.

In one embodiment, the relative position of the focal bands is moved in a range between 10% and 50%. In one embodiment, the second focal zone is simultaneously emitted from a single transducer element. In one embodiment, the method comprises the steps of: the focal zone is imaged with an ultrasound imaging element. In one embodiment, the system is designed to work non-invasively to treat tissue. In one embodiment, the method functions in a non-invasive manner to treat tissue.

In various embodiments, ultrasound imaging is employed to ensure adequate acoustic coupling during administration of an ultrasound therapy treatment. In various embodiments, ultrasound imaging is employed to prevent treatment at undesired regions in the body, such as bones or implants. Unlike light, sound requires a medium for propagation. In an embodiment, an ultrasound therapy system acoustically couples acoustic energy from a transducer to a body by means of an acoustic window using a gel. In this embodiment, the gel is a medium that mimics the acoustic impedance characteristics of the tissue, and therefore, there is efficient transfer of energy from the device into the tissue. Unfortunately, any air pockets between the transducer and the tissue prevent proper coupling and thus may cause insufficient transfer of ultrasound therapy energy. Ultrasound imaging examines the coupling. The insufficient coupling may appear as shadows or longitudinal stripes in the ultrasound image or as a completely dark image. Even if there is sufficient coupling, tissues or objects such as bones or implants can pose challenges because these objects may have different acoustic impedance and absorption characteristics than soft tissue (e.g., skin, muscle). Because of this, objects (such as bone or implants) between the device and the intended treatment focus may cause significant reflections and apparent heating at shallower depths than intended. Objects that are slightly beyond the focal length (e.g., bones, etc.) may also cause problems because they reflect and readily absorb ultrasound from soft tissue. The reflected energy may inadvertently add to the energy already at the treatment focus, causing a higher temperature rise than expected. The energy absorbed at the bone may cause heating or discomfort in the bone.

In various embodiments, advantages of the present invention include using images to assess coupling of an ultrasound treatment beam to the intended treatment tissue. In various embodiments, higher resolution imaging is advantageous for providing more detail in the image of the target tissue and nearby tissue for treatment. In various embodiments, the present invention improves safety characteristics, improves efficacy performance, provides safety and efficacy components of an integrated heating device for plastomers, submental fat, abdomen and/or flanks, arms, inner thighs, outer thighs, buttocks, laxity, abdominal laxity, etc. (such as band therapy, linear focus therapy bands, cylindrical focal lines, planes and/or volumes, etc.), provides qualitative and/or quantitative assessment of coupling, provides blending of high resolution images with coupled images, is employed to assess out-of-plane obstructions (e.g., bones, intestines, implants) after focusing, and/or may be used to reduce the need for a sonographer equivalent technique.

In various embodiments, an ultrasound therapy and imaging system includes: an ultrasound probe, comprising: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image tissue; and an acoustic window, wherein the ultrasound imaging transducer comprises an annular imaging array; wherein the ultrasound imaging transducer comprises a plurality of transmit channels; wherein the ultrasound imaging transducer comprises a plurality of receive channels; wherein the ultrasound imaging transducer is configured to focus at a location proximate the ultrasound imaging transducer with respect to a distance between the ultrasound imaging transducer and the acoustic window; and a control module coupled to the ultrasound probe for controlling the ultrasound imaging transducer, wherein the ultrasound imaging transducer is configured to interrogate more than 40% of the acoustic window.

In various embodiments, an ultrasound therapy and imaging system includes: an ultrasound probe, comprising: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image tissue; and an acoustic window, wherein the ultrasound imaging transducer comprises an annular imaging array; wherein the ultrasound imaging transducer comprises a plurality of transmit channels; wherein the ultrasound imaging transducer comprises a plurality of receive channels; wherein the ultrasound imaging transducer operates at an imaging frequency between 8MHz and 50MHz, wherein the ultrasound imaging transducer is configured to image tissue at a depth of up to 25mm (e.g., 5mm, 8mm, 10mm, 12mm, 15mm, 20mm) below the skin surface; wherein the ultrasound imaging transducer is configured to focus at a location behind the ultrasound imaging transducer with respect to the acoustic window; and a control module coupled to the ultrasound probe for controlling the ultrasound imaging transducer, wherein the ultrasound imaging transducer is configured to interrogate more than 10% of the acoustic window.

In various embodiments, an ultrasound therapy and imaging system includes: an ultrasound probe, comprising: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image tissue; and an acoustic window, wherein the ultrasound imaging transducer comprises an annular or linear imaging array; wherein the ultrasound imaging transducer comprises a plurality of transmit channels; wherein the ultrasound imaging transducer comprises a plurality of receive channels; wherein the ultrasound imaging transducer operates at an imaging frequency between 8MHz and 50MHz, wherein the ultrasound imaging transducer is configured to image tissue up to a depth of 25mm below the skin surface; wherein the ultrasound imaging transducer is configured to focus at a location proximate the ultrasound imaging transducer with respect to a distance between the ultrasound imaging transducer and the acoustic window; and a control module coupled to the ultrasound probe for controlling the ultrasound imaging transducer, wherein the ultrasound imaging transducer is configured to interrogate more than 15% of the acoustic window.

In one embodiment, the imaging beam width from the ultrasound imaging transducer is at least 20% of the cross-sectional dimension of the treatment beam width from the ultrasound therapy transducer. In one embodiment, the imaging beam width from the ultrasound imaging transducer is at least 30% of the cross-sectional dimension of the treatment beam width from the ultrasound therapy transducer. In one embodiment, the imaging beam width from the ultrasound imaging transducer is at least 40% of the cross-sectional dimension of the treatment beam width from the ultrasound therapy transducer. In one embodiment, the imaging beam width from the ultrasound imaging transducer is at least 50% of the cross-sectional dimension of the treatment beam width from the ultrasound therapy transducer. In one embodiment, the imaging beam width from the ultrasound imaging transducer is at least 80% of the cross-sectional dimension of the treatment beam width from the ultrasound therapy transducer.

In one embodiment, the coupling of imaging by the ultrasound imaging transducer provides an indication of the coupling for therapy by the ultrasound therapy transducer. In one embodiment, the ultrasound imaging transducer is configured to interrogate more than 80% of the acoustic window. In one embodiment, the ultrasound imaging transducer is configured to interrogate more than 90% of the acoustic window. In one embodiment, the annular imaging array is positioned in an ultrasound therapy transducer.

In one embodiment, the control module controls an ultrasound imaging transducer for vector imaging. In one embodiment, the control module controls an ultrasound imaging transducer for defocus vector imaging.

In one embodiment, the ultrasound therapy transducer is configured to treat tissue at a first set of locations positioned within a first cosmetic treatment band and a second set of locations positioned within a second cosmetic treatment band, the first band being different from the second band. In one embodiment, the ultrasound therapy transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby portions of the ultrasound transducer are adapted to transmit ultrasound therapy at acoustic intensities of a plurality of amplitudes, wherein the first amplitude is different from the second amplitude. In one embodiment, at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more amplitudes of acoustic intensity, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezoelectric body varies over time. In one embodiment, the ultrasound transducer comprises a piezoelectric material, and the plurality of portions of the ultrasound transducer are adapted to produce a plurality of corresponding changes in the piezoelectric material in response to an electric field applied to the ultrasound transducer. In one embodiment, the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material. In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy via phase shifting, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity in a plurality of phases, wherein the first phase is different from the second phase. In one embodiment, the plurality of phases comprises discrete phase values. In one embodiment, the ultrasound transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy at a plurality of amplitudes of acoustic intensity, wherein the first amplitude is different from the second amplitude; and applying ultrasound therapy, whereby portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity in a plurality of phases, wherein the first phase is different from the second phase.

In various embodiments, the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder area improvement, hip lifting, scar reduction, burn treatment, skin tightening (e.g., abdominal relaxation treatment), blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, and cellulite treatment.

In various embodiments, a method of confirming coupling between an ultrasound probe and treated tissue includes the steps of: setting: an ultrasound probe comprising an acoustic window; an ultrasound transducer comprising an ultrasound therapy transducing element adapted to apply ultrasound therapy to tissue; a plurality of imaging transducing elements being an array, the plurality of imaging transducing elements for imaging tissue; and a control module coupled to the ultrasound probe for controlling the ultrasound transducer; and interrogating at least 20% of the acoustic window with imaging beams from the plurality of imaging transducer elements.

In one embodiment, the plurality of imaging transducer elements queries at least 30% of the acoustic window. In one embodiment, the plurality of imaging transducing elements interrogates at least 40% of the acoustic window. In one embodiment, the plurality of imaging transducing elements interrogates at least 50% of the acoustic window.

In one embodiment, the plurality of imaging transducing elements interrogates at least 60% of the acoustic window. In one embodiment, the plurality of imaging transducing elements interrogates at least 70% of the acoustic window. In one embodiment, the method further comprises vector imaging. In one embodiment, the method further comprises defocus vector imaging. In one embodiment, the method further comprises the steps of: a first focal zone in the tissue is imaged with a plurality of imaging transducer elements. In one embodiment, the method further comprises the steps of: a second focal zone in the tissue is imaged with the plurality of imaging transducer elements. In various embodiments, the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder lift, hip lift, scar reduction, burn treatment, tattoo removal, skin tightening (e.g., laxity treatment), vein removal, vein reduction, treatment of sweat glands, treatment of hyperhidrosis, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

In several embodiments, systems and methods are provided that successfully improve ultrasonic imaging of tissue while moving, such as when an omnidirectional transducer is on a motion mechanism. In various embodiments, higher resolution is achieved. In various embodiments, better imaging signal quality is obtained. In various embodiments, ultrasound imaging is used in conjunction with therapeutic tissue treatment.

In various embodiments, an ultrasound therapy and imaging system configured to reduce imaging misalignment, the ultrasound therapy and imaging system comprising: an ultrasound probe, comprising: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image tissue; and a motion mechanism for moving the ultrasound imaging transducer in a first direction and a second direction. In an embodiment, the ultrasound imaging transducer is mechanically attached to the motion mechanism. In an embodiment, the first direction is linear. In an embodiment, the second direction is linear. In an embodiment, the first direction is parallel to the second direction. In an embodiment, the first direction is opposite to the second direction. In an embodiment, the ultrasound imaging transducer images in a first focal band sequence order (f1, f2) when traveling in a first direction, the ultrasound imaging transducer images in a second focal band sequence order (f2, f1) when traveling in a second direction, and spatial registration between the first direction imaging and the second direction imaging is improved by staggering trigger positions. In an embodiment, the control module is coupled to the ultrasound probe for controlling the ultrasound imaging transducer.

In various embodiments, an ultrasound therapy and imaging system configured to reduce imaging misalignment includes: an ultrasound probe, comprising: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image tissue; and a motion mechanism for moving the ultrasound imaging transducer in a first direction and a second direction. In an embodiment, the ultrasound imaging transducer is mechanically attached to the motion mechanism, wherein the first direction is linear, wherein the second direction is linear, wherein the first direction is parallel to the second direction, wherein the first direction is opposite to the second direction, wherein the ultrasound imaging transducer images in a first focal zone sequence (f1, f2, f3, f4) when traveling in the first direction, the ultrasound imaging transducer images in a second focal zone sequence (f4, f3, f2, f1) when traveling in the second direction, wherein spatial registration between the first direction imaging and the second direction imaging is improved by interleaving trigger positions, wherein the imaging system employs a sequence of two consecutive a-lines that continuously follow a sequence of numbers (line 1: f1, f2, f3, f 4; line 2: f4, f3, f2, f 1); and a control module coupled to the ultrasound probe for controlling the ultrasound imaging transducer.

In various embodiments, an ultrasound therapy and imaging system configured to reduce imaging misalignment includes: an ultrasound probe, comprising: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image tissue; and a motion mechanism for moving the ultrasound imaging transducer in a first direction and a second direction. In an embodiment, the ultrasound imaging transducer is mechanically attached to the motion mechanism. In an embodiment, the first direction is opposite to the second direction. In an embodiment, an ultrasound imaging transducer images in a focal zone sequence (f 1.., fN) while traveling in a first direction, where N > 1. In an embodiment, the ultrasound imaging transducer images in a second focal zone sequence (fN,..., f1) while traveling in the second direction. In an embodiment, spatial registration between the first and second direction imaging is improved by staggering the trigger positions. In an embodiment, the imaging system employs a direction dependent focal zone ordering that alternates between (f1-. fN) and (fN-. f1) on consecutive a-lines; and a control module coupled to the ultrasound probe for controlling the ultrasound imaging transducer.

In an embodiment, the first direction of motion of the transducer is any one or more of the group consisting of: linear, rotational, and curved. In an embodiment, the second direction is a reverse path of the first direction. In an embodiment, the first direction of motion occurs in a plurality of dimensions and the second direction is a reverse path of the first direction. In an embodiment, the ultrasound imaging transducer images sequentially with a first sequence of focal bands designated as (f 1., fN), where N > 1. In an embodiment, the ultrasound therapy transducer is configured to treat tissue at a first set of locations positioned within a first cosmetic treatment band and a second set of locations positioned within a second cosmetic treatment band, the first band being different from the second band. In an embodiment, the ultrasound therapy transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity at a plurality of amplitudes, wherein the first amplitude is different from the second amplitude. In an embodiment, at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more amplitudes of acoustic intensity, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezoelectric body varies over time. In an embodiment, the ultrasound transducer comprises a piezoelectric material, and the plurality of portions of the ultrasound transducer are adapted to produce a plurality of corresponding piezoelectric material changes in response to an electric field applied to the ultrasound transducer. In an embodiment, the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material. In an embodiment, the ultrasound transducer is adapted to apply the ultrasound treatment via a phase shift, whereby the portions of the ultrasound transducer are adapted to transmit the ultrasound treatment of acoustic intensities of a plurality of phases, wherein the first phase is different from the second phase. In an embodiment, the plurality of phases comprises discrete phase values. In an embodiment, the ultrasound transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby the portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity at a plurality of amplitudes, wherein the first amplitude is different from the second amplitude; and applying ultrasound therapy, whereby portions of the ultrasound transducer are adapted to transmit ultrasound therapy of acoustic intensity in a plurality of phases, wherein the first phase is different from the second phase. In various embodiments, the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder lift, hip lift, scar reduction, burn treatment, skin tightening (e.g., laxity treatment), blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, cellulite treatment, vaginal rejuvenation, and acne treatment.

In various embodiments, a method of reducing imaging misalignment in a moving ultrasound probe, the method comprising the steps of: interleaving trigger positions of spatial registration between first direction imaging and second direction imaging with an ultrasound probe, the ultrasound probe comprising: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image tissue; and a motion mechanism for moving the ultrasound imaging transducer in a first direction and a second direction, wherein the ultrasound imaging transducer is mechanically attached to the motion mechanism, wherein the first direction is opposite the second direction, wherein the ultrasound imaging transducer images in a focal zone sequence order (f 1.., fN), N >1, wherein the ultrasound imaging transducer images in a first focal zone sequence order (f 1.., fN) when traveling in the first direction, wherein the ultrasound imaging transducer images in a second focal zone sequence order (fN,.., f1) when traveling in the second direction.

In an embodiment, N is any one of the group consisting of: 2. 3, 4, 5, 6, 7, 8, 9 and 10. In an embodiment, N is 4. In various embodiments, the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder area improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening (e.g., abdominal laxity treatment), vein removal, vein reduction, treatment of sweat glands, treatment of hyperhidrosis, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

The methods summarized above and set forth in more detail below describe specific actions taken by a practitioner; however, it should be understood that they may also include instructions for these actions of another party. Thus, actions such as "fluttering the energy beam" include "indicating flutter of the energy beam".

In some implementations, a system includes various features that are present as a single feature (as opposed to multiple features). For example, in one embodiment, the system includes a single transducer element that generates two simultaneous treatment foci of flutter. In alternative embodiments, a plurality of features or components are provided. In various embodiments, a system includes, consists essentially of, or consists of one, two, three, or more embodiments of any feature or component disclosed herein. In some embodiments, features or components are not included and may be disclaimed negatively from the particular claims so that the system lacks such features or components.

Further areas of applicability will become apparent from the description provided herein. It should be understood that the description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the embodiments disclosed herein.

Drawings

The drawings described herein are for illustration purposes only and are not intended to limit the scope of the present disclosure in any way. Embodiments of the present invention will become more fully understood from the detailed description and the accompanying drawings, wherein:

figure 1A is a schematic diagram of an ultrasound system according to various embodiments of the present invention.

Figure 1B is a schematic diagram of an ultrasound system according to various embodiments of the present invention.

Figure 1C is a schematic diagram of an ultrasound system according to various embodiments of the present invention.

Figure 2 is a schematic diagram of an ultrasound system coupled to a region of interest according to various embodiments of the present invention.

FIG. 3 is a schematic diagram of a portion of a transducer according to various embodiments of the invention.

Figure 4 is a partially cutaway side view of an ultrasound system according to various embodiments of the present invention.

FIG. 5 is a table illustrating focus separation for apertures having different spatial frequencies according to various embodiments of the present invention.

FIG. 6 is a graph illustrating focus separation for apertures having different aperture spatial frequencies according to various embodiments of the present invention.

FIG. 7 is a graph illustrating focus separation for apertures having different aperture spatial frequencies according to various embodiments of the present invention.

FIG. 8 is a schematic illustration of aperture polarization with spatial frequencies that can be modified by excitation of channels according to various embodiments of the invention.

FIG. 9 is a schematic illustration of a polarized ceramic having a spatial frequency that may be modified by excitation of channels covering two polarized regions of the ceramic, according to various embodiments of the invention.

FIG. 10 is a schematic diagram of an embodiment of an array transducer with an imaging transducer.

FIG. 11 is a schematic diagram of an embodiment of the array transducer of FIG. 10 having a mechanical focal point, a first electronic focal point, and a second electronic focal point.

Figure 12 is a schematic diagram of an embodiment of an intensity map for a treatment with two focal lengths of 15mm and 17 mm.

Figure 13 is a schematic diagram of an embodiment of an intensity map for a treatment with two focal lengths of 15mm and 19 mm.

Figure 14 is a schematic illustration of a cross-section of the difference between the size of an ultrasound treatment beam compared to an ultrasound imaging beam, according to various embodiments of the present invention.

FIG. 15 is a schematic diagram of a linear array according to various embodiments of the invention.

FIG. 16 is a schematic view of an annular array according to various embodiments of the present invention.

FIG. 17 is a schematic illustration of a circular array compared to a linear array, according to various embodiments of the present invention.

FIG. 18 is a schematic diagram of an annular array with a virtual focus behind the array, according to various embodiments of the invention.

Figure 19 is a schematic diagram of an annular array with a virtual focus between the array and an acoustic window, according to various embodiments of the present invention.

Fig. 20 is a schematic illustration of the temporal progression of transmit-receive vectors for normal B-mode imaging, according to various embodiments of the invention.

FIG. 21 is a schematic diagram of an interlaced imaging method according to various embodiments of the invention.

Figure 22 is a schematic diagram of an imaging method with a synthetic transmit and receive aperture method according to various embodiments of the present invention.

Figure 23 is a schematic diagram of an imaging diagnostic ultrasound system according to various embodiments of the present invention.

Fig. 24 is a schematic illustration of bi-directional imaging at the same lateral position, according to various embodiments of the present invention.

FIG. 25 is a schematic illustration of direction dependent focal zone ordering according to various embodiments of the invention.

FIG. 26 is a schematic illustration of direction dependent focal zone sequencing with different trigger positions according to various embodiments of the present invention.

FIG. 27 is a schematic illustration of the direction dependent focal band ordering alternating between (fl-f2-f3-f4) & (f4-f3-f2-fl) on consecutive A lines according to various embodiments of the present invention.

FIG. 28 is a schematic diagram of a transducer of various embodiments of the present invention, as viewed from a convex side, a side cross-section, and a concave side.

FIG. 29 is a schematic view of a transducer of various embodiments of the present invention, as viewed from a convex side, a side cross-section, and a concave side.

FIG. 30 is a schematic diagram of a transducer of various embodiments of the present invention, as viewed from a convex side, a side cross-section, and a concave side.

FIG. 31 is a schematic diagram of a transducer of various embodiments of the present invention, as viewed from a convex side, a side cross-section, and a concave side.

FIG. 32 is a schematic diagram of a transducer of various embodiments of the present invention, as viewed from a convex side, a side cross-sectional view, and a concave side.

FIG. 33 is a schematic diagram of a transducer of various embodiments of the present invention, as viewed from a convex side, a side cross-sectional view, and a concave side.

Detailed Description

The following description sets forth examples of embodiments, and is not intended to limit the invention or its teachings, applications, or uses. It should be understood that throughout the drawings, corresponding reference numerals indicate like or corresponding parts and features. The description of the specific examples indicated in the various embodiments of the invention are intended for purposes of illustration only and are not intended to limit the scope of the invention disclosed herein. Moreover, recitation of multiple embodiments having stated features is not intended to exclude other embodiments having additional features, or other embodiments incorporating different combinations of the stated features. Further, features from one embodiment (such as in one figure) may be combined with descriptions (and figures) of other embodiments.

In various embodiments, systems and methods for ultrasound treatment of tissue are adapted and/or configured to provide cosmetic treatment. In some embodiments, devices and methods are provided in several embodiments that direct ultrasound therapy to a single focal point or multiple simultaneous focal points, employ ultrasound imaging to confirm sufficient acoustic coupling to the treatment region for improved performance, or to provide improved correlation between movement in first and second directions when forming images in cosmetic and/or medical procedures. In some embodiments, devices and methods are provided in several embodiments that employ ultrasound imaging to confirm sufficient acoustic coupling to a treatment region when directing ultrasound treatment to a single focus or multiple simultaneous focuses during cosmetic and/or medical procedures in order to improve performance and safety. In some embodiments, the apparatus and method for improved ultrasound imaging provide better correlation between movement in the first and second directions when forming an image. Embodiments of the present invention provide better imaging correlation between the first and second movement directions (e.g., better correlation between left and right travel formed images). Apparatus and methods for improved ultrasound imaging improve the effectiveness of B-mode imaging more quickly (e.g., 1.5x, 2x, 3x, 5x scan rate). In various embodiments, tissue below and even at the surface of the skin, such as the epidermis, dermis, fascia, muscle, fat, and superficial muscle aponeurosis system ("SMAS"), is non-invasively treated with ultrasound energy. The ultrasound energy may be focused at one or more treatment points and/or zones, may be unfocused and/or defocused, and may be applied to a region of interest including at least one of epidermis, dermis, hypodermis, fascia, muscle, fat, cellulite, and SMAS to achieve cosmetic and/or therapeutic effects. In various embodiments, the systems and/or methods provide non-invasive dermatological treatment to tissue by thermal treatment, coagulation, ablation, and/or tightening. In several embodiments disclosed herein, non-invasive ultrasound is used to achieve one or more of the following effects: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair (e.g., cheekback, treatment of infraorbital laxity), wrinkle removal, fat reduction (e.g., treatment of fat and/or cellulite), cellulite treatment (e.g., treatment of female lipodystrophy, dimpled or non-dimpled), low neck-to-shoulder improvement (e.g., upper chest), hip lifting (e.g., tightening of the buttocks), skin loosening treatment (e.g., treatment of tissue for tightening or abdominal loosening treatment), scar reduction, burn treatment, tattoo removal, vein reduction, treatment of sweat glands, treatment of hyperhidrosis, freckle removal, acne treatment, and pimple removal. In one embodiment, fat reduction is achieved. In various embodiments, a reduction in cellulite (e.g., female lipodystrophy or dented or non-dented) or an improvement in one or more characteristics (such as dent, nodular status, "orange peel" appearance, etc.) is achieved by about 10% -20%, 20% -40%, 40% -60%, 60% -80%, or more (and covering an internal range) as compared to, for example, untreated tissue. In one embodiment, the low neck exposed shoulder is treated. In some embodiments, two, three, or more beneficial effects are achieved during the same treatment session and may be achieved simultaneously.

Various embodiments of the present invention relate to devices or methods for controlling the delivery of energy to tissue. In various embodiments, the various forms of energy may include acoustic, ultrasonic, optical, laser, Radio Frequency (RF), microwave, electromagnetic, radiation, thermal, cryogenic, electron beam, photon-based, magnetic-responsive, and/or other forms of energy. Various embodiments of the present invention relate to an apparatus or method for dividing an ultrasonic energy beam into a plurality of beams. In various embodiments, the device or method may be used to alter the delivery of ultrasonic acoustic energy in any process, such as, but not limited to, therapeutic ultrasound, diagnostic ultrasound, ultrasonic welding, any application involving the coupling of mechanical waves to an object, and other processes. Generally, with therapeutic ultrasound, a tissue effect is achieved by focusing acoustic energy using a focusing technique from an aperture. In some cases, High Intensity Focused Ultrasound (HIFU) is used as such for therapeutic purposes. In one embodiment, the tissue effect produced by the application of therapeutic ultrasound at a particular depth may be referred to as the production of hot freezing point (TCP). In some embodiments, the band may include dots. In some embodiments, the band is a line, plane, sphere, ellipse, cube, or other one-, two-, or three-dimensional shape. Thermal and/or mechanical ablation of tissue may occur non-invasively or remotely by means of generating TCP at a specific location. In some embodiments, the ultrasound treatment does not include cavitation and/or shock waves. In some embodiments, the ultrasound therapy comprises cavitation and/or shock waves.

In one embodiment, the TCPs may be produced in linear or substantially linear, curved or substantially curved bands or sequences, with each individual TCP being separated from adjacent TCPs by a treatment interval. In one embodiment, multiple sequences of TCP may be generated in the treatment region. For example, TCP may be formed along a first sequence and a second sequence separated from the first sequence by a treatment distance. While treatment with therapeutic ultrasound can be managed by generating individual TCPs in a sequence and multiple sequences of individual TCPs, it may be desirable to reduce the treatment time and corresponding risk of pain and/or discomfort experienced by a patient. Treatment time can be reduced by forming multiple TCPs simultaneously, nearly simultaneously, or sequentially. In some embodiments, treatment time may be reduced by 10%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80% or more by generating multiple TCPs.

Various embodiments of the present invention address potential challenges posed by the management of ultrasound therapy. In various embodiments, the time to achieve formation of a TCP at a target tissue for a desired cosmetic and/or therapeutic treatment of a desired clinical procedure is reduced. In various embodiments, the target tissue is, but is not limited to: any of the skin, eyelids, eyelashes, eyebrows, caruncle, crow's feet, wrinkles, eyes, nose, mouth (e.g., nasolabial folds, perioral wrinkles), tongue, teeth, gums, ears, brain, heart, lung, ribs, abdomen (e.g., for abdominal laxity), stomach, liver, kidney, uterus, chest, vagina, prostate, testis, glands, thyroid, viscera, hair, muscle, bone, ligament, cartilage, fat, lipped lip, adipose tissue, subcutaneous tissue, transplanted organ, lymph, tumor, cyst, abscess, or a portion of a nerve, or any combination thereof.

Various embodiments of ultrasound treatment and/or imaging devices are described in U.S. application No.12/996616 issued as U.S. publication No.2011-0112405a1 on 12.2011, which is a national phase of U.S. under 35u.s.c. § 371 of international application No. pct/US2009/046475, filed on 5.6.2009 and published on 10.12.10.2009 in 2009, which claims the benefit of priority of U.S. provisional No.61/059477, filed on 6.6.2008, each of which is incorporated herein by reference in its entirety. Various embodiments of ultrasound treatment and/or imaging apparatus are described in U.S. application No.14/193234, issued as U.S. publication No.2014/0257145 on 9/11 2014, which is hereby incorporated by reference in its entirety. Various embodiments of ultrasound treatment and/or imaging apparatus are described in international application PCT/US15/25581, published as WO 2015/160708 on day 22/10/2015 with national phase US application No.15/302436, published as US publication No.2017/0028227 on day 2/2017, each of which is incorporated herein by reference in its entirety.

Overview of the System

Referring to the illustration in fig. 1A, 1B, and 1C, various embodiments of an ultrasound system 20 include a hand wand (e.g., handpiece) 100, modules (e.g., transducer modules, cassettes, probes) 200, and a controller (e.g., console) 300. In some implementations, the console 300 includes a communication system (e.g., wifi, bluetooth, modem, etc.) that communicates with another party, manufacturer, vendor, service provider, the internet, and/or the cloud. In some embodiments, cart 301 provides mobility and/or positioning of system 20, and may include wheels, surfaces on which components are written or placed, and/or compartments 302 (e.g., drawers, containers, shelves, etc.) that store or organize the components, for example. In some embodiments, the cart has a power source, such as a power connection to a battery and/or one or more cords connecting the power source, communication to the system 20 (e.g., ethernet). In some embodiments, system 20 includes cart 301. In some embodiments, system 20 does not include cart 301. Hand wand 100 may be coupled to controller 300 by interface 130, which may be a wired or wireless interface. Interface 130 may be coupled to hand wand 100 by a joint 145. The distal end of the interface 130 may be connected to a controller connector on the circuit 345 (not shown). In one embodiment, interface 130 may send controllable power from controller 300 to hand wand 100. In an embodiment, the system 20 has multiple imaging channels (e.g., 8 channels) for ultra-high definition HD (high definition) visualization of subcutaneous structures to improve imaging. In an embodiment, the system 20 has multiple treatment channels (e.g., 8 channels) and a precision linear drive motor that doubles the treatment accuracy while increasing the speed (e.g., by 25%, 40%, 50%, 60%, 75%, 100%, or more). At the same time, these features establish one of the most common system platforms in the industry and provide the basis for unprecedented future possibilities.

In various embodiments, the controller 300 may be adapted and/or configured to operate with the hand wand 100 and module 200 and the overall ultrasound system 20 functionality. In various embodiments, a plurality of controllers 300, 300 ', 300 ", etc. may be adapted and/or configured to operate with a plurality of hand bars 100, 100 ', 100", etc. and/or a plurality of modules 200, 200 ', 200 ", etc. The controller 300 may include a connection to one or more interactive graphical displays 310, which may include a touch screen monitor and a Graphical User Interface (GUI) that allows a user to interact with the ultrasound system 20. In one embodiment, a second smaller, more mobile display that allows the user to more easily locate and view the treatment screen. In one embodiment, the system user is allowed to view a second display of the treatment screen (e.g., on a wall, on a mobile device, a large screen, a remote screen). In one embodiment, the graphical display 310 includes a touch screen interface 315 (not shown). In various embodiments, the display 310 sets up and displays operating conditions, including device activation status, treatment parameters, system messages and prompts, and ultrasound images. In various embodiments, the controller 300 may be adapted and/or configured to include, for example, a microprocessor with software and input/output devices, systems and devices for controlling electronic and/or mechanical scanning and/or multiplexing of the transducers and/or multiplexing of the transducer modules, systems for power delivery, systems for monitoring, systems for sensing the spatial position of the probe and/or transducer and/or multiplexing of the transducer modules, and/or systems for processing user inputs and recording treatment results, among others. In various embodiments, the controller 300 may include a system processor and various analog and/or digital control logic, such as one or more of a microcontroller, microprocessor, field programmable gate array, computer board, and associated components including firmware and control software, which may be capable of interfacing with user control and interface circuitry as well as input/output circuitry and systems for communication, display, interfacing, storage, documentation, and other useful functions. The system software running on the system process may be adapted and/or configured to control all initialization, timing, level setting, monitoring, safety monitoring, and all other ultrasound system functions for accomplishing the user-defined treatment goal. Further, the controller 300 may include various input/output modules, such as switches, buttons, and the like, which may also be adapted and/or configured to control the operation of the ultrasound system 20.

In one embodiment, hand wand 100 includes one or more finger-actuated controls or switches, such as 150 and 160. In various embodiments, one or more thermal treatment controllers 160 (e.g., switches, buttons) start and/or stop treatment. In various embodiments, one or more imaging controllers 150 (e.g., switches, buttons) start and/or stop imaging. In one embodiment, hand wand 100 may include a removable module 200. In other embodiments, the module 200 may be non-removable. In various embodiments, module 200 may be mechanically coupled to hand wand 100 using latch or coupler 140. In various embodiments, interface guide 235 or a plurality of interface guides 235 may be used to facilitate coupling of module 200 to hand wand 100. The module 200 may include one or more ultrasound transducers 280. In some implementations, the ultrasound transducer 280 includes one or more ultrasound elements. The module 200 may include one or more ultrasound elements. Hand wand 100 may include an imaging only module, a therapy only module, an imaging and therapy module, and the like. In various implementations, the ultrasonic transducer 280 is movable in one or more directions 290 within the module 200. The transducer 280 is connected to a motion mechanism 400. In various embodiments, the motion mechanism includes zero, one, or more bearings, shafts, rods, screws, lead screws 401, encoders 402 (e.g., optical encoders that measure the position of the transducer 280), motors 403 (e.g., stepper motors) to help ensure accurate and repeatable movement of the transducer 280 within the module 200. In various embodiments, module 200 may include a transducer 280 that may emit energy via acoustically transparent member 230. In one embodiment, control module 300 may be coupled to hand wand 100 via interface 130, and graphical user interface 310 may be adapted and/or configured to control module 200. In one embodiment, control module 300 may provide power to hand wand 100. In one embodiment, hand wand 100 may include a power source. In one embodiment, switch 150 may be adapted and/or configured to control tissue imaging functions and switch 160 may be adapted and/or configured to control tissue treatment functions. In various embodiments, the delivery of the emitted energy 50 at a suitable depth of focus, with a suitable distribution, at a suitable time, and at a suitable energy level is provided by the module 200 via controlled operation of the control system 300 of the transducer 280 to achieve a desired therapeutic effect with respect to the thermal coagulation zone 550.

In one embodiment, module 200 may be coupled to hand wand 100. The module 200 may transmit and receive energy, such as ultrasonic energy. Module 200 may be electronically coupled to hand wand 100, and such coupling may include an interface to communicate with controller 300. In one embodiment, interface guide 235 may be adapted and/or configured to provide electronic communication between module 200 and hand wand 100. The module 200 may include various probe and/or transducer configurations. For example, the module 200 may be adapted and/or configured for combining dual mode imaging/therapy transducers, coupling or co-housing imaging/therapy transducers, separate therapy and imaging probes, and the like. In one embodiment, upon insertion of module 200 into hand wand 100 or connection to hand wand 100, controller 300 automatically detects it and updates interactive graphical display 310.

In some embodiments, access key 320 (e.g., secure USB drive, key) is removably connected to system 20 to allow system 20 to function. In various embodiments, the access key is programmed to be customer specific and serves a number of functions including system security, country/region specific access to treatment guidelines and functions, software updates, support log transfer and/or credit transfer and/or storage. In various embodiments, the system 20 has an internet and/or data connection. In an embodiment, the connection provides a method by which data is transferred between the system 20 provider and the customer. In various embodiments, the data includes credits, software updates, and support logs. Connections are divided into different model implementations based on how the user's console connects to the internet. In one embodiment, the disconnected model connection includes a console that is disconnected from the Internet and the customer does not have Internet access. The credit transfer and software update is performed by shipping an access key (e.g., a USB drive) to the customer. In one embodiment, a semi-connected model connection includes a console that is disconnected from the Internet but the customer has Internet access. Credit transfer, software updates, and support log transfer occur using a customer's personal computer, smart phone, or other computing device along with system access keys to transfer data. In one embodiment, a fully connected model connection includes a console wirelessly connected to the internet using wifi, cellular modem, bluetooth, or other protocols. Credit transfer, software updates, and support log transfer are done directly between the console and the cloud. In various embodiments, system 20 connects to an online portal for streamlined invention management, on-demand treatment procurement, and business analysis insights to drive customer aesthetic treatment business to the next level.

In various embodiments, tissue below and even at the surface of the skin, such as the epidermis, dermis, hypodermis, fascia, and superficial muscle aponeurosis system ("SMAS") and/or muscle, is non-invasively treated with ultrasound energy. The tissue may also include blood vessels and/or nerves. The ultrasound energy may be focused, unfocused, and/or defocused and may be applied to a region of interest including at least one of epidermis, dermis, hypodermis, fascia, and SMAS to achieve a therapeutic effect. Fig. 2 is a schematic diagram of an ultrasound system 20 coupled to a region of interest 10. In various embodiments, the tissue layer of the region of interest 10 may be at any part of the subject's body. In one embodiment, the tissue layers are in the head and facial regions of the subject. The cross-sectional portion of tissue of the region of interest 10 includes a skin surface 501, an epidermis layer 502, a dermis layer 503, a fat layer 505, a superficial muscle aponeurosis system 507 (hereinafter "SMAS 507"), and a muscle layer 509. The tissue may also include a hypodermis 504, which may include any tissue below the dermal layer 503. The combination of these layers in total may be referred to as subcutaneous tissue 510. Also illustrated in fig. 2 is a treatment zone 525 below the surface 501. In one embodiment, surface 501 may be a surface of the skin of subject 500. While embodiments directed to treatment at tissue layers may be used as examples herein, the system may be applicable to any tissue in the body. In various embodiments, the systems and/or methods may be used for tissues (including, but not limited to, one or a combination of muscle, fascia, SMAS, dermis, epidermis, fat, adipocytes, cellulite, which may be referred to as a female lipodystrophy (e.g., non-dimpled female lipodystrophy), on the face, neck, head, arms, legs, or any other location on or in the body, including body cavities). In various embodiments, cellulite (e.g., non-dent female lipodystrophy) is reduced by an amount that is 2%, 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 75%, 80%, 90%, 95%, and any range within.

Referring to the illustration of FIG. 2, an embodiment of the ultrasound system 20 includes a hand wand 100, a module 200, and a controller 300. In one embodiment, the module 200 includes a transducer 280. Fig. 3 illustrates an embodiment of an ultrasound system 20 having a transducer 280 adapted and/or configured to treat tissue at a focal depth 278. In one embodiment, the depth of focus 278 is the distance between the transducer 280 and the target tissue being treated. In one embodiment, the depth of focus 278 is fixed for a given transducer 280. In one embodiment, the depth of focus 278 is variable for a given transducer 280. In one embodiment, the transducer 280 is configured to treat at multiple depths (e.g., 1.5mm, 3.0mm, 4.5mm, or other depths) below the skin surface simultaneously.

Referring to the illustration in fig. 4, the module 200 may include a transducer 280 that may emit energy via the acoustically transparent member 230. In various embodiments, the depth may refer to the depth of focus 278. In one embodiment, transducer 280 may have an offset distance 270, which is the distance between transducer 280 and the surface of acoustically transparent member 230. In one embodiment, the depth of focus 278 of the transducer 280 is a fixed distance from the transducer. In one embodiment, transducer 280 may have a fixed offset distance 270 from the transducer to acoustically transparent member 230. In one embodiment, the acoustically transparent member 230 is adapted and/or configured on the module 200 or ultrasound system 20 at a location that contacts the skin surface 501. In various embodiments, the depth of focus 278 exceeds the offset distance 270 by an amount corresponding to treatment at a target region located at a tissue depth 279 below the skin surface 501. In various embodiments, the tissue depth 279 is the distance between the acoustically transparent member 230 and the target area when the ultrasound system 20 is placed in physical contact with the skin surface 501, measured as the distance from the portion of the hand wand 100 or module 200 surface that contacts the skin (with or without an acoustic coupling gel, medium, etc.) and the depth into the tissue of the target area from the skin surface contact point. In one embodiment, depth of focus 278 may correspond to the sum of offset distance 270 (as measured for the surface of acoustically transparent member 230 in contact with coupling medium and/or skin 501) plus tissue depth 279 below skin surface 501 to the target area. In various embodiments, acoustically transparent member 230 is not used.

The coupling components may include various substances, materials, and/or devices that facilitate coupling of the transducer 280 or module 200 to a region of interest. For example, the coupling component may comprise an acoustic coupling system adapted and/or configured for acoustic coupling of ultrasonic energy and signals. An acoustic coupling system with possible connections such as a manifold can be used to couple sound into the region of interest, providing liquid or fluid filled lens focusing. The coupling system may facilitate this coupling by using one or more coupling media, including air, gas, water, liquid, fluid, gel, solid, non-gel, and/or any combination thereof, or any other medium that allows signals to be transmitted between the transducer 280 and the region of interest. In one embodiment, one or more coupling media are disposed inside the transducer. In one embodiment, the fluid-filled module 200 contains one or more coupling mediums inside the housing. In one embodiment, the fluid-filled module 200 contains one or more coupling mediums inside a sealed housing that is separable from the dry portion of the ultrasound device. In various embodiments, the coupling medium is used to transmit ultrasonic energy between one or more devices and tissue with a transmission efficiency of 100%, 99% or more, 98% or more, 95% or more, 90% or more, 80% or more, 75% or more, 60% or more, 50% or more, 40% or more, 30% or more, 25% or more, 20% or more, 10% or more, and/or 5% or more.

In various embodiments, the transducer 280 may image and treat a region of interest at any suitable tissue depth 279. In one embodiment, the transducer module 280 may provide acoustic power in a range of about 1W or less, about 1W to about 100W, and more than about 100W (e.g., 200W, 300W, 400W, 500W). In one embodiment, the transducer module 280 can provide acoustic power at frequencies of about 1MHz or less, about 1MHz to about 10MHz (e.g., 3MHz, 4MHz, 4.5MHz, 7MHz, 10MHz), and more than about 10 MHz. In one embodiment, the module 200 has a focal depth 278 for treatment at a tissue depth 279 of about 4.5mm below the skin surface 501. In one embodiment, the module 200 has a focal depth 278 for treatment at a tissue depth 279 of about 3mm below the skin surface 501. In one embodiment, the module 200 has a focal depth 278 for treatment at a tissue depth 279 of about 1.5mm below the skin surface 501. Some non-limiting embodiments of the transducer 280 or module 200 may be adapted and/or configured to deliver ultrasonic energy at tissue depths of any depth anywhere and within the range of 1.5mm, 3mm, 4.5mm, 6mm, 7mm, less than 3mm, between 3mm and 4.5mm, between 4.5mm and 6mm, more than 4.5mm, more than 6mm, etc., and 0-3mm, 0-4.5mm, 0-6mm, 0-25mm, 0-100mm, etc. In one embodiment, the ultrasound system 20 is provided with two or more transducer modules 280. For example, a first transducer module may apply therapy at a first tissue depth (e.g., about 4.5mm), and a second transducer module may apply therapy at a second tissue depth (e.g., about 3mm), and a third transducer module may apply therapy at a third tissue depth (e.g., about 1.5-2 mm). In one embodiment, at least some or all of the transducer modules may be adapted and/or configured to apply therapy at substantially the same depth.

In various embodiments, changing the number of focal spot positions (e.g., such as having a tissue depth 279) used for the ultrasound procedure may be advantageous because it permits treatment of the patient at varying tissue depths even when the focal depth 278 of the transducer 270 is fixed. This may provide synergistic results and maximize the clinical outcome of a single treatment session. For example, treatment at multiple depths below a single surface area allows for a greater total volume of tissue treatment, which results in enhanced collagen formation and compaction. In addition, treatments at different depths affect different types of tissue, producing different clinical effects that together provide enhanced overall cosmetic results. For example, superficial treatments may reduce the visibility of wrinkles, and deeper treatments may induce the formation of more collagen growth. Also, treatment at various locations at the same or different depths may improve treatment.

While treatment of a subject at different locations in one session may be advantageous in some embodiments, sequential treatment over time may be advantageous in other embodiments. For example, the subject may receive treatment under the same surface area at one depth at time one, at a second depth at time two, and so on. In various embodiments, the time may be on the order of nanoseconds, microseconds, milliseconds, seconds, minutes, hours, days, weeks, months, or other time periods. The new collagen produced by the first treatment may be more sensitive to subsequent treatments, which may be desirable for some indications. Alternatively, multiple depth treatments under the same surface region in a single segment may be advantageous because the treatment at one depth may synergistically enhance or supplement the treatment at another depth (e.g., due to enhanced blood flow, stimulation by growth factors, hormonal stimulation, etc.). In several embodiments, different transducer modules provide treatment at different depths. In one embodiment, a single transducer module may be adjusted or controlled for varying depths. A security feature that minimizes the risk that the error depth will be selected may be used in conjunction with a single modular system.

In several embodiments, a method of treating a lower face and neck region (e.g., a submental region) is provided. In several embodiments, a method of treating (e.g., softening) the folds of the chin lip is provided. In other embodiments, a method of treating an ocular region (e.g., a zygomatic pocket, treating infraorbital laxity) is provided. The improvement of upper eyelid laxity and periorbital and textural improvements will be achieved by several embodiments by treatment at variable depths. By treating at varying locations in a single treatment session, optimal clinical results (e.g., softening, tightening) can be achieved. In several embodiments, the treatment methods described herein are non-invasive cosmetic procedures. In some embodiments, the methods may be used in conjunction with invasive procedures where skin tightening is desired, such as surgical facial wrinkle removal or liposuction. In various embodiments, the methods may be applied to any part of the body.

In one embodiment, the transducer module 200 allows for a fixed depth treatment sequence at or below the skin surface. In one embodiment, the transducer module allows for a treatment sequence at one, two or more variable or fixed depths below the dermis layer. In several embodiments, the transducer module includes a motion mechanism adapted and/or configured to guide ultrasound therapy in a sequence of independent thermal foci (hereinafter "thermal coagulation points" or "TCP") at a fixed focal depth. In one embodiment, the sequence of independent TCPs has a treatment interval in the range of from about 0.01mm to about 25mm (e.g., 1mm, 1.5mm, 2mm, 2.5mm, 3mm, 5mm, 10mm, 20mm, and any range of values within), which interval flutters by 1% to 50% (e.g., 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, and any range within). For example, the spacing may be 1.1mm or less, 1.5mm or more, between about 1.1mm to about 1.5mm, and the like. In one embodiment, the independent TCPs are discrete. In one embodiment, independent TCPs overlap. In one embodiment, the movement mechanism is adapted and/or configured to be programmed to provide a variable spacing between the independent TCPs. In one embodiment, the flutter is adapted and/or configured to provide a variable spacing between individual TCPs. In several embodiments, the transducer module includes a motion mechanism adapted and/or configured to direct the ultrasound therapy in a sequence such that the TCP is formed in a linear or substantially linear sequence separated by a therapy distance. For example, the transducer module may be adapted and/or configured to form a TCP along a first linear sequence and a second linear sequence separated from the first linear sequence by a treatment distance. In one embodiment, the therapeutic distance between adjacent linear sequences of independent TCPs is in the range from about 0.01mm to about 25 mm. In one embodiment, the therapeutic distance between adjacent linear sequences of independent TCPs is in the range from about 0.01mm to about 50 mm. For example, the treatment distance may be 2mm or less, 3mm or more, between about 2mm to about 3mm, and the like. In several embodiments, the transducer module may include one or more motion mechanisms 400 adapted and/or configured to direct ultrasound therapy in a sequence such that TCP is formed in a linear or substantially linear sequence of individual thermal foci separated from other linear sequences by a treatment distance. In one embodiment, the treatment is applied in a first direction 290 (e.g., pushing). In one embodiment, the treatment is applied opposite (e.g., pulled) from the first direction 290. In one embodiment, the treatment is applied in and opposite (e.g., pushing and pulling) to the first direction 290. In one embodiment, the treatment distances separating linear or substantially linear TCP sequences are the same or about the same. In one embodiment, the treatment distance separating linear or substantially linear TCP sequences is different or substantially different for various adjacent pairs of linear TCP sequences.

In one embodiment, first and second movable transducer modules are provided. In one embodiment, each of the first and second transducer modules is adapted and/or configured for both ultrasound imaging and ultrasound therapy. In one embodiment, the transducer module is adapted and/or configured for therapy only. In one embodiment, the imaging transducer may be attached to the handle of the probe or hand wand. The first and second transducer modules are adapted and/or configured to be interchangeably coupled to the hand wand. The first transducer module is adapted and/or configured to apply ultrasound therapy to a first layer of tissue, and the second transducer module is adapted and/or configured to apply ultrasound therapy to a second layer of tissue. The second layer of tissue is at a different depth than the first layer of tissue.

As illustrated in fig. 3, in various embodiments, the delivery of the emitted energy 50 at a suitable depth of focus 278, with a suitable distribution, at a suitable time, and at a suitable energy level is provided by the module 200 via controlled operation of the control system 300 to achieve a desired therapeutic effect of controlled thermal injury to treat at least one of the epidermal layer 502, the dermal layer 503, the fat layer 505, the SMAS layer 507, the muscle layer 509, and/or the hypodermis 504. FIG. 3 illustrates one embodiment of a depth corresponding to a depth for treating a muscle. In various embodiments, the depth may correspond to any tissue, tissue layer, skin, epidermis, dermis, hypodermis, fat, SMAS, muscle, blood vessel, nerve, or other tissue. During operation, the module 200 and/or transducer 280 may also be mechanically and/or electronically scanned along the surface 501 to treat an extended region. Monitoring of the treatment area and surrounding structures may be provided before, during, and after delivery of ultrasound energy 50 to at least one of the epidermis layer 502, dermis layer 503, hypodermis 504, fat layer 505, SMAS layer 507, and/or muscle layer 509 to plan and assess the results and/or provide feedback to the controller 300 and user via the graphical interface 310.

In one embodiment, the ultrasound system 20 generates ultrasound energy that is directed and focused below the surface 501. The controlled and focused ultrasonic energy 50 produces a hot freezing point or zone (TCP) 550. In one embodiment, the ultrasonic energy 50 creates a cavity in the subcutaneous tissue 510. In various embodiments, the emitted energy 50 targets tissue below the surface 501 that cuts, ablates, coagulates, microeblates, manipulates, and/or causes TCP 550 in the portion of tissue 10 below the surface 501 at the specified depth of focus 278. In one embodiment, during a treatment sequence, transducer 280 is moved in the direction indicated by arrow 290 marked with designated intervals 295 to produce a series of therapy bands 254, each of which receives transmitted energy 50 to produce one or more TCPs 550. In one embodiment, the labeled arrow 291 illustrates an axis or direction orthogonal to the arrow 290, and the spacing of the TCPs 550 illustrates that the TCPs may be spaced orthogonally to the direction of motion of the transducer 280. In some embodiments, the orientation of the spaced TCPs may be set at any angle 180 degrees from arrows 2900. In some embodiments, the orientation of the spaced-apart TCPs may be set to any angle between 0-180 degrees based on the orientation of the polarized regions on transducer 280.

At each locationIn one embodiment, the transducer module may include one or more transducing elements. The transducing element may include a piezoelectrically active material such as lead zirconate titanate (PZT) or any other piezoelectrically active material such as piezoelectric ceramics, crystals, plastics, and/or composites and lithium niobate, lead titanate, barium titanate, and/or lead metaniobate. In various embodiments, the transducer module may include any other material suitable and/or configured to generate radiant and/or acoustic energy in addition to or in lieu of a piezoelectrically active material. In various embodiments, the transducer module may be adapted and/or configured to operate at different frequencies and treatment depths. The transducer characteristics may be represented by an outer diameter ("OD") and a depth of focus (F)_L) To be defined. In one embodiment, the transducer may be adapted and/or configured to have an OD of 19mm and F_L15 mm. In other embodiments, other suitable values of OD and F may be used_LSuch as an OD of less than about 19mm, greater than about 19mm, etc., and an F of less than about 15mm, greater than about 15mm, etc_L. The transducer module may be adapted and/or configured to apply ultrasound energy at different target tissue depths. As described above, in several embodiments, the transducer module includes a motion mechanism adapted and/or configured to direct ultrasound therapy in a linear or substantially linear sequence of independent TCPs with therapy intervals between the independent TCPs. For example, the treatment interval may be about 1.1mm, 1.5mm, etc. In several embodiments, the transducer module may further comprise motion mechanisms adapted and/or configured to direct the ultrasound therapy in a sequence such that the TCP is formed in a linear or substantially linear sequence separated by therapy intervals. For example, the transducer module may be adapted and/or configured to form a TCP along a first linear sequence and a second linear sequence separated from the first linear sequence by a treatment interval of between about 2mm and 3 mm. In one embodiment, the user may manually move the transducer module across the surface of the treatment region such that a contiguous linear sequence of TCPs is generated. In one embodiment, the motion mechanism may automatically move the transducer module across the surface of the treatment region such that adjacent linear sequences of TCPs are generated.

Aperture spatial frequency analysis and Fourier transform

In various embodiments, spatial frequency analysis techniques based on fourier analysis and fourier optics may be used to improve the efficiency of therapeutic treatment. When a system with an impulse response h (t) is excited by a stimulus x (t), the relationship between the input x (t) and the output y (t) is related by a convolution function as follows:

in various embodiments, a fourier transform may be applied to calculate the convolution of equation (1). The continuous one-dimensional fourier transform can be defined as:

here, f is frequency and t is time. It can be shown that the convolution in the time domain is equivalent to a multiplication in the frequency domain:

F(x(t)*h(t))＝X(f)H(f)＝Y(f) (3)

in various embodiments, a Fraunhofer approximation may be used to derive the relationship between the transducer opening or aperture and the resulting ultrasound beam response. Derivation of the Fraunhff approximation is described in Joseph Goodman, Introduction to Fourier Optics (3 rd edition, 2004), which is incorporated herein by reference in its entirety. According to the frenhun hough approximation, the far field complex amplitude pattern produced by the complex aperture is equal to the two-dimensional fourier transform of the aperture amplitude and phase. In several embodiments, this relationship in optics may be extended to ultrasound, as linear wave equations may be used to represent both light propagation and acoustic propagation. In the case of optical and/or ultrasound, a two-dimensional fourier transform can determine the acoustic pressure amplitude distribution at the focal point of the transducer.

For a focused system, the variable z representing depth may be z representing focal length_fInstead.

In various embodiments, fourier optical and fourier transform identities (some of which are listed in table 1 below) may be used for the ultrasound transducer in order to determine an intensity distribution corresponding to the transducer design. For example, the Fourier transform of the rectangular rect (ax) is the sinc (sinc) function. As another example, a Fourier transform of a two-dimensional circle of uniform amplitude is what may be denoted as J₁First order Bessel (Bessel) functions.

TABLE 1

In several embodiments, the ultrasound transducer may have a rectangular aperture of suitable dimensions and focal length. In several embodiments, the ultrasound transducer may have a circular aperture of suitable dimensions and focal length. In one embodiment, the transducer may have a circular aperture with an outer radius of approximately 9.5mm, an inner diameter of approximately 2mm, and a focal length of approximately 15 mm. The aperture of a circular transducer can be described as:

for example, in one embodiment, the variable "a" may be approximately 9.5mm, and the variable "b" in equation (5a) may be approximately 2 mm. Applying a fourier transform to equation (5a) can provide an estimate of the acoustic pressure profile at the focal point.

Wherein, ξ_xAnd ξ_yF of equations (4a) and (4b)_xAnd f_yThe same is true. Equation (6) demonstrates that the acoustic pressure profile of a transducer with a circular aperture is a first order bessel function. In one embodiment, the majority of the energy is concentrated at the focal point (e.g., 15mm from the aperture). The width of the main ultrasound beam and the distribution of energy away from the main beam can be expressed as a function of the operating frequency as expressed in equations (4a) and (4 b).

In various embodiments, if the aperture is modulated (e.g., multiplied by the correction function) by the correction function, two identical or nearly identical beams can be produced at the focal point. In one embodiment, the cosine function may be applied to a circular aperture as follows:

the energy distribution or beam response at the focus of the modulated aperture of equation (7) is the convolution of the fourier transforms of two functions of the aperture:

equation (8) can be simplified to the sum of two separate functions by applying the fourier transform identity (e.g., identity 2 in table 2) for the Dirac delta function:

equation (9) shows that the two beams appearing at the focal point are spatially shifted compared to the original unmodulated beamIn several embodiments, one or more other modulation functions, such as a sinusoidal function, may be used to achieve the desired beam response. In several embodiments, the aperture may be modulated such that more than two focal points are produced. For example, three, four, five, etc. focal points may be generated. In several embodiments, the aperture may be modulated such that the focal points are produced sequentially or substantially sequentially (rather than simultaneously).

In several embodiments, the treatment transducer module includes a motion mechanism configured to direct ultrasound treatment in a linear or substantially linear sequence of independent TCPs having treatment intervals between the independent TCPs, e.g., the treatment intervals may be about 1.1mm, 1.5mm, etc. in several embodiments, the transducer module may further include motion mechanisms configured to direct ultrasound treatment in a sequence such that the TCPs are formed in linear or substantially linear sequences separated by the treatment intervals, e.g., the transducer module may be configured to form a TCP along a first linear sequence and a second linear sequence separated from the first linear sequence by a treatment interval of between about 2mm and 3mm, according to equation (9), simultaneous or substantially simultaneous segmentation of ultrasound beams at the focus (or before the focus) may be achieved if the aperture is modulated by a cosine and/or sine function of the desired spatial frequency, in one embodiment, two simultaneous or almost simultaneous or nearly simultaneous focused beams separated by a treatment interval of about 1.1mm may be generated in a linear or substantially linear sequence at a spatial frequency of ξ mm in ultrasound water, a wavelength of approximately ξ mm in water_xAnd ξ_yIs represented as:

to place the two focal points approximately 1.1mm apart, the spatial frequency for the modulation aperture is then calculated as follows. Using the identities 3 and 4 in table 2, the fourier transform of the sine or cosine function is a dirac delta function with arguments:

in one embodiment, k may be assigned when the argument is 0_xSolving equation (11 a):

further, x_oOne half of the separation distance (e.g., 1.1mm) may be substituted:

in several embodiments, transducers having circular apertures that transmit ultrasound energy at various operating frequencies may be modulated by sine and/or cosine functions at the spatial frequencies listed in Table 2. As indicated in table 2, the modulated aperture of the transducer may produce a simultaneously or substantially simultaneously split beam having two focal points with different separation distances. In one embodiment, the transducer may have an OD of about 19mm and a focal length of about 15 mm.

TABLE 2

As shown in table 2, in several embodiments, the spatial frequency of the aperture modulation function increases with increasing ultrasound operating frequency for a given focal point separation distance. In addition, the spatial frequency increases as the desired focus separation distance increases.

In one embodiment, higher spatial frequencies may produce faster occurring amplitude transitions in the aperture. Due to transducer processing limitations, rapid amplitude changes in the aperture may make the aperture less efficient because there may be variations in the amount of acoustic pressure generated by different portions of the aperture. In one embodiment, using spatial frequencies to divide the beams simultaneously or nearly simultaneously may reduce the overall focus gain of each beam. As shown in equation (9), the field pressure at the focus of each beam is reduced by a factor of two compared to the unmodulated beam. In one embodiment, the acoustic pressure or ultrasound intensity from the aperture may be increased to obtain a similar or substantially similar intensity at the focal plane. However, in one embodiment, increasing the pressure at the aperture may not be limited by system and/or transducer processing limitations. In one embodiment, an increase in pressure at the aperture may increase the overall intensity in the near field, which may increase the likelihood of overheating tissue in the treatment region located in front of the focal point. In one embodiment, the possibility of additionally heating the pre-focused tissue may be limited or eliminated by using a lower ultrasound treatment frequency.

In one embodiment, applying an aperture modulation function as shown in equation (7) results in two simultaneous or substantially simultaneous ultrasound beams at the focal point. In various embodiments, the ultrasound beam may be divided multiple times, such as three times, four times, five times, etc., such that multiple simultaneous or nearly simultaneous beams are produced. In one embodiment, four equally spaced beams along one dimension may be generated by modulating or multiplying an aperture by two separate spatial frequencies:

the unmodulated beam at the focal point can be produced at four different positions along the x-axis, as shown in equation (12 b). In one embodiment, a constant or DC term C1 may be added to the amplitude modulation function to maintain the placement of the energy at the original focal position:

in one embodiment, the aperture modulation of equations (12) and (13) by which the beam is placed at multiple locations simultaneously or nearly simultaneously may have limited applicability due to system, material, and/or tissue limitations. In one embodiment, due to the possibility of heating tissue in the treatment region located in front of the focal point, the frequency of the ultrasound treatment may be adjusted (such as reduced) in order to limit and/or eliminate such a possibility. In one embodiment, to limit and/or eliminate the possibility of heating the tissue before focusing, a non-linear technique may be applied at the focal point. In one embodiment, the acoustic pressure or ultrasound intensity from the aperture may be increased to obtain a similar or substantially similar intensity at the focal plane.

In various embodiments, the sound pressure function U (x) if the amplitude and phase functions at the aperture are separable₁,y₁) The two-dimensional fourier transform of (a) may be expressed as the product of the one-dimensional fourier transforms of two functions of x and y. In various entitiesIn embodiments, it may be advantageous to generate multiple TCPs in a linear or substantially linear sequence and simultaneously or nearly simultaneously generate multiple linear sequences.

Electron dithering of multiple beam split apertures using frequency modulation

In various embodiments, table 2 illustrates aperture spatial frequencies for achieving a particular distance between two simultaneous focal points for a given operating frequency (e.g., 4MHz, 7MHz, 10MHz in various embodiments). Equation (11c) shows that the separation distance between the focal points is also a function of the operating frequency. For example, in one embodiment, the aperture (k)_x) Is fixed to 1.0mm^-1And allows the operating frequency to vary. Equation 11c can be rewritten to show how the focus separation distance can be modulated by the operating frequency.

s＝(k_xz_fv_c)/(πf_op) (14)

Wherein k is_xIs given in units of mm^-1Spatial frequency of z_fIs the depth of focus in mm of the aperture, v_cIs the velocity of ultrasound in a propagation medium (e.g., water) in mm/sec, and f_opIs the operating frequency of the aperture in MHz. In one embodiment, the following substitution is made in equation 11 c:

λ＝v_c/f_op(15)

the separation distance of the focal points is a function of the operating frequency, as shown in equation (14). Further, the ratio of the change in separation distance to the operating frequency is:

ds/df_op＝-(k_xz_fv_c)/(πf_op ²) (16)

equation (16) shows that the separation distance decreases as the operating frequency increases. Table 3 (below) shows the rate of change of separation distance as a function of operating frequency for different spatial frequencies (e.g., 4MHz, 7MHz, 10MHz in various embodiments).

TABLE 3

As shown in table 3, the focal points are closer together as the operating frequency increases and farther apart as the operating frequency decreases without the need to change phase or mechanically move the transducer. This is the only way to move the beam electronically to spread the energy without relying on thermal conduction in the tissue. Benefits include a reduction or minimization of maximum temperature and an increase in thermal coagulation volume of the lesion without the need for additional system channels.

The amount of movement from the primary operating frequency can be determined by using equation (14). In one embodiment, the main operating frequency of the aperture is 5MHz and the focal length is 15 mm. In some embodiments, the operating frequency is referred to as the aperture center frequency. In one embodiment, the operating frequency is 5 MHz. In one embodiment, Table 4 at FIG. 5 shows different spatial frequencies (k) as designed for a center frequency of 5MHz_x0.5, 1.0, 1.5, 2.0 (unit is mm)^-1) The amount of focus separation of the aperture. It also calculates the amount of spread from the focal point for a center frequency of 5 MHz. According to one embodiment, the spacing is reduced for higher frequencies relative to 5MHz and increased for lower frequencies relative to 5 MHz.

Fig. 6 shows the difference in spacing of all operating frequencies of an aperture for different aperture spatial frequencies. As shown in fig. 6, the separation distance increases as the frequency decreases.

In one embodiment, the separation distance is related to a frequency of 5 MHz. In one embodiment, one way to estimate the electronic dither from the frequency modulation may be determined by referencing all of the movements to the initial separation of 5 MHz. As shown in fig. 7, the spread of the separation distance between the focal points may easily vary by more than 1 mm.

In various embodiments, the range of possible operating frequencies from one aperture may be described in view of the transducer bandwidth. In one embodiment, the larger transducer bandwidth results in an aperture with a wider range of operating frequencies. The transducer bandwidth can be described as a percentage of the aperture center frequency by locating the frequency at which the transmit intensity is reduced to-3 dB of the peak transmit intensity. In one embodiment, for transmit response of the transducer aperture, the-3 dB high frequency is designated as f_-3db,HAnd-3 dB low frequency is designated as f_-3dB,L. In units of [ MHz]The-3 dB center frequency of (a) is described as:

f_-3dB,center＝(f_-3dB,H+f_-3dB,L)/2 (17)

the 3dB percent bandwidth is described as:

BW_-3dB＝100％*(f_-3dB,H-f_-3dB,L)/((f_-3dB,H+f_-3dB,L)/2) (18)

in some embodiments, increasing the range of possible operating frequencies within an aperture may be accomplished (but is not limited to) through the use of a backing layer, matching layer, multiple piezoelectric layers, electrical matching, piezoelectric composites, and/or single crystal piezoelectric ceramics. In one embodiment, the range of possible separation distances increases as the transducer bandwidth increases. Table 5 (below) shows how the focus spread can vary based on the percentage bandwidth at an aperture center frequency of 5 MHz. Focal separation distance for 5MHz for 0.5mm^-1、1.00mm^-1、1.50mm^-1、2.00mm^-10.72mm, 1.43mm, 2.15mm and 2.86mm, respectively. If the spatial frequency at the aperture is 1.50mm^-1And the transducer bandwidth is 60%, then the separation distance between the focal points varies by 1.42mm, a distance greater than the lateral resolution of the beam at 5 MHz.

Additional diffusion from 5MHz center frequency in [ mm ]

TABLE 5

In one embodiment, as the frequency varies, the depth of field as well as the lateral resolution and focus gain will also vary. In one embodiment, as the frequency varies, the depth of field, lateral resolution, and focus gain will also vary. Thus, in one embodiment, the intensity at the aperture may vary depending on the heating rate target. Also, in some embodiments, it may be advantageous to transmit multiple operating frequencies simultaneously to spread the energy immediately or near immediately. For example, the transmit excitation of the aperture may include excitation of 4MHz, 5MHz, and 6MHz all simultaneously.

Multiple focal points by varying aperture spatial frequency

As equation 11c shows, the higher the aperture spatial frequency, the greater the separation distance between the focal points. In one embodiment, the spatial frequency k is used_xA polarizing aperture. As shown in the embodiment in fig. 8, the spatial frequency can be easily doubled or reduced to zero by connecting separate electrically activated channels with the ability to modify the phase to 0 degrees or 180 degrees. For example, if the phase on channels 1 to 16 is 0 degrees, then the aperture spatial frequency is k_x. In an embodiment, as the phase on each channel changes from 0 degrees to 180 degrees such that the odd channel is at 0 degrees and the even channel is at 180 degrees, then the spatial frequency at the aperture is 1/2k_x. In an embodiment, if the phase repeats every two channels such that channels 1 and 2 are 0 degrees and channels 3 and 4 are 180 degrees, then the spatial frequency at the aperture is 0. If channel 1 is 0 degrees, channel 2 is 180 degrees, channel 3 is 180 degrees, channel 4 is 0 degrees, and so on, then the spatial frequency at the aperture is 2k_x. In this case, seven unique focal points may be generated. As shown in Table 4(Annotated at fig. 5), if the aperture center frequency is 5MHz and the aperture frequency is 0mm^-1、0.5mm^-1、1.0mm^-1Or 2.0mm^-1Of 0mm, 0.72mm, 1.43mm and 2.86mm, which results in seven unique focal positions separated by 0.36 mm. In various embodiments, an intermediate phase between 0 and 180 degrees will further allow the two focal points to be tilted so that a line of focal points can be produced in the focal plane. Finally, the tilting, the modulation of the focus position and the frequency modulation enable the heating and possible freezing of the whole line with a length of approximately 2.86 mm.

In one embodiment, as shown in FIG. 9, the polarized ceramic has 2k_xThe spatial frequency of (a). In this case, each electrical channel covers two polarized regions in the ceramic (e.g., piezoelectric ceramic). If channels 1 to 8 have the same electrical phase, the spatial frequency of the aperture is 2k_x. If the phases are alternated such that the odd channels have a phase of 0 degrees and the even channels have a phase of 180 degrees, then the spatial frequency of the aperture is k_x. In one embodiment, this configuration, where only two phases are possible on the channel, enables four unique focal points. In various embodiments, if additional phases are allowable, the two focal points may be tilted to many different focal positions. This configuration limits the number of electron channels required to achieve multiple focal positions.

Multiple focal points using multi-channel signal mixing

In several embodiments, the therapy system uses multiple therapy channels to enable electronic focusing and/or steering. For example, a treatment system that uses multiple treatment channels to enable electronic focusing and/or steering allows faster electronic dithering to produce more thermal coagulation using the same amount of energy as other treatment devices, or to produce equal thermal coagulation using electronic dithering with less energy than other treatment devices. This technique broadens the therapeutic efficacy and comfort continuum provided by the device. In addition to electronic dithering, the multiple treatment channels also provide the possibility of moving the beam to different depth positions, so that two conventional transducers, such as DS7-4.5 (7 MHz at 4.5mm depth) and DS7-3.0 (7 MHz at 3.0mm depth) can be replaced with one single device that moves between two different depths.

In one embodiment, the transducer 280 with multiple treatment channels 281 connected to move the beam axially (e.g., annular array) will typically first produce TCP 550 at a deep depth and then move to a shallower depth. In another embodiment, TCP 550 is produced at a shallow depth, and then TCP is produced at a deeper depth below the skin surface. This sequence produces TCP 550 and will result in extended treatment times. For example, in one embodiment, if the time for deep TCP 550 is t_deepAnd the time for the shallow TCP 550 is t_shallowThen the total treatment time for two TCPs 550 is two treatment times t_deepPlus t_shallowThe sum of (1). In one embodiment, the total treatment time is reduced by forming multiple (two or more) TCPs 550 simultaneously using signal mixing techniques that use both signal apodization (coloring) and phase control at each channel. In one embodiment, the total treatment time is t_deepAnd t_shallowIs measured.

Treatment time, traditional method: t is t_treatment＝t_deep+t_shallow

Treatment time, signal mixing: t is t_treatment＝max(t_deep,t_shallow)

In an embodiment, the annular array design 280 enables electronic movement of the treatment beam in depth (e.g., by changing the depth of the TCP 550 below the skin surface). In one embodiment, transducer 280 includes an eight treatment channel annular transducer element 281 having a fixed mechanical focus. FIG. 10 illustrates a top view of an embodiment of the ceramic annular array design 280 with an imaging transducer 285 at the center of the bowl. In this embodiment, the therapeutic ring transducer 280 has eight rings corresponding to elements 281 identified as Tx 0-Tx 7. FIG. 11 shows a side view of the same eight channel ring transducer 280 with hash marks representing the boundaries between rings. In this embodiment, eight separate excitation sources have been connected to separate annular ring 281. In addition to electrical excitation, a geometric focus 551 and two electronic foci 552, 552' have also been identified.

In one embodiment, there is a unique amplitude "a" and phase "8" applied to each treatment channel and corresponding annular ring 281 for each focal point at a given treatment frequency 'ω'. The excitation function for the channel can be generalized to the following form:

f_n，m(t)＝A_n，msin(ωt+θ_n，m)

(19)

where n is the ring or channel number and m is the focal number.

In the case of TCP generated at the geometric focus, the phase is zero and equation (19) can be rewritten as:

f_n，1(t)＝A_n，1sin(ωt)

(20)

wherein a "1" in the subscript indicates the geometric focus.

In the case of TCP 550 generation at electronic focus #2, the phase of the loop must be adjusted to focus the ultrasound at a point in space using bowl geometry and time delay estimates. The firing function can be written as:

f_n，2(t)＝A_n，2sin(ωt+θ_n，2)

(21)

where '2' in the subscript denotes electron focal point #2, and the angle is the desired phasing for the ring.

Now, in the conventional case, two TCPs will be produced in sequence, typically first a deeper TCP and then a shallow TCP. However, signal mixing allows the two excitation signals to be represented as one signal, so that two TCPs can be generated simultaneously.

f_n，total(t)f_n，1(t)+f_n，2(t)＝A_n，1sin(ωt)+A_n，2sin(ωt+θ_n，2)(22a)

f_n，tota1(t)＝c sin(ωt+φ)

(22b)

Wherein c ═ sqrt (A)_n，1 ²+A_n，2 ²+2A_n，1A_n，2cos(θ)_n，2) And are) and

φ＝atan2(A_n，2sin(θ_n，2)，A_n，1+A_n，2cos(θ_n，2))

the amplitude and phase at each ring is modified to support focusing at two locations simultaneously.

In some embodiments, the time to deliver the dose for one focus will be slightly different from the second focus. In one embodiment, the excitation may begin or end at a focal point with a longer dosing time, with the excitation modified to support dosing at both focal points simultaneously during other times using equation (22 b). For example, in one embodiment, for f_n，1Total administration time of 30 milliseconds is required, whereas for f_n，2A total administration time of 60 milliseconds is required. To meet this, many different excitation schemes may be used:

f of 30msec_n，2(t) and then f of 30msec_n，total(t) (23a)

F of 30msec_n，total(t) and then f of 30msec_n，2(t) (23b)

F of 15msec_n，2(t) and then f of 30msec_n，total(t) and f of 15msec_n，2(t) (23c)

In one embodiment, the concept may be further generalized to more than two simultaneous foci.

Suppose the excitation on one ring is as follows:

where n is the ring number and m is the number of simultaneous foci. This generalization to more than two foci enables simultaneous delivery of geometric, shallow and deep electron foci.

In one embodiment, experiments were conducted using simulations that completed two simultaneous foci to show that, when applying this theory, two foci occurred. The simulation attempted to place the theoretical focus at 15mm and 17mm simultaneously. Figure 12 shows an intensity map at azimuth and depth of this simultaneous excitation. The intensity map clearly shows the two foci that occur at 15mm and 17 mm. Another simulation was performed with the focus at 15mm and 19mm, respectively. Fig. 13 shows the results. In various embodiments, the techniques may be applied to any array. The array may be annular, linear or any electronically controlled array transducer.

Ultrasound imaging for improved ultrasound therapy treatment

In an embodiment, imaging resolution is improved via electron focusing on the beam axis in the transmit and receive signals. In various embodiments, the imaging resolution is increased by 10%, 20%, 40%, or 50%, 10% -50%, or any value within. In an embodiment, because the treatment beam is much wider in cross-section than the imaging beam at the tissue interface, increasing the imaging resolution also fails to interrogate the coupling between the treatment transducer and the skin.

Fig. 14 illustrates an embodiment in which the cross-section of the therapy beam 281 from the therapy transducer 280 is compared to the cross-section of the imaging beam 286 from the imaging transducer 285 through the acoustic window interface. In this figure, the movement of the transducer 280 is in and out of the page. As shown in fig. 14, the OD of the treatment cross-section is significantly larger than the imaging cross-section. Analysis using trigonometry and simple ray tracing showed that: a treatment transducer with a 4MHz treatment beam directed at a depth of 4.5mm below the skin surface (DS4-4.5) had a treatment beam OD 281 of 8mm, while an imaging beam OD 286 was expected to be approximately 0.25 mm. In this case, only approximately 0.1% of the treatment beam passing through the acoustic window is interrogated if a small imaging beam is used to check for proper coupling. In embodiments, this estimate may be slightly underestimated due to diffraction effects of the treatment beam.

In an embodiment, imaging beam 286 is expected to be a larger (e.g., 10%, 15%, 25%, 50%, 75%, 90%, 100%) entire image frame to cover more or all of the treatment beam 281 cross-section. In an embodiment, the image has a width of 25 mm. If the areas (e.g., slice thickness and width) are calculated and compared, the imaging plane only queries approximately 2.5% of the total treatment region cross-section at the acoustic window. Although this is an improvement over the initial calculation, it is still significantly less than 100% coverage. In various embodiments, imaging provides for suitably interrogating more (e.g., 10%, 15%, 25%, 50%, 75%, 90%, 100%) coupling using an imaging system having a circular array. In some embodiments, image processing is initiated by an operator with appropriate interpretation.

Linear imaging array

In various embodiments, an ultrasound therapy system includes an imaging module and an imaging array 285. In various embodiments, the imaging array 285 is a linear array, such as shown in the embodiment at fig. 15. In one embodiment, a method for detecting the amount of acoustic coupling between tissue and an ultrasound therapy system is to use a linear array that is oriented in the transducer module such that the electronic steering and focusing of the beam is along the y-and z-dimensions. This is orthogonal to the direction of movement with the motion mechanism. In this embodiment, the linear array focuses the imaging beam multiple times in the imaging plane as the transducer is moved along the x-axis, which generates a high resolution ultrasound image. The imaging beam may also be steered and focused away from the imaging plane as the linear array is translated along the x-axis to better assess the coupling of the treatment beam cross-section into the tissue. In some cases, this may give an even better spatial determination of the differential coupling region than a circular array due to the spatial specificity of the imaging beam. This is particularly true when the linear array is a 1.25D, 1.5D, 1.75D or 2D array.

Annular imaging array

In various embodiments, an ultrasound therapy system includes an imaging module and an imaging array 285. In various embodiments, to image the skin to approximately 25mm in depth, the imaging module has multiple (e.g., 2, 4, 8) transmit channels and multiple (e.g., 2, 4, 8) receive channels operating from 8MHz to 50MHz (e.g., 8, 9, 10, 12, 15, 20, 22, 25, 28, 30, 40, or 50MHz and any range within). In one embodiment, to image the skin to approximately 25mm in depth, the imaging module has eight transmit channels and eight receive channels, which operate from 8MHz to 50 MHz. The eight channels enable a unique imaging aperture design with elements that provide electronic steering and focusing at both transmit and receive. One of these types of apertures is a circular array (fig. 16).

In some embodiments, the circular array 285 contains a ring of equal element regions that permit electron focusing along the beam axis. In one embodiment, the mechanically scanned circular array 285 provides superior imaging performance over more technically advanced, electronically controlled linear arrays 285'. This is because the circular array 285 focuses the beam along the beam axis in azimuth and elevation. Radial symmetry produces a high resolution beam with an equivalent beam width. The linear array 285' uses electronic focusing in azimuth and mechanical focusing in elevation, which is equivalent to a compound lens. The beam resolution in azimuth may match the performance of the circular array 285; however, the resolution of the beam in elevation is inferior to the circular array 285 because the mechanical lens has only one depth of focus.

Fig. 17 illustrates an embodiment of the focusing capabilities of the circular array 285 when compared to the linear array 285' in elevation. The beam width 286 remains narrow throughout the depth of the circular array 285. However, this narrow beam width 286 limits the acceptable level of interrogation of the treatment beam before focusing (e.g., when tissue is coupled) and after focusing (e.g., at the bone).

In one embodiment, the circular array 285 is superior to standard imaging transducers because it can be focused on the beam axis at both transmit and receive times. Just as the circular array 285 can be focused in tissue, it can also be effectively focused behind the transducer 285. This focus behind the imaging array 285 defocuses the acoustic energy propagating toward the tissue so that the likelihood of treating coupling behind the acoustic window and treating an obstruction (e.g., bone) behind the focus can be better queried. FIG. 18 illustrates an embodiment of the virtual focus and effective response toward tissue behind the circular imaging array 285. The defocused beam 286 diffuses from the imaging array 285 toward the acoustic window, such that a greater percentage (e.g., 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, and any range or value within) of the coupling of the treatment beam is queried. Another transmit focus, depending on the particular beam width and penetration characteristics, may be used to defocus the beam behind the treatment focus. This can be done by placing the virtual focus point after the circular array 285 or immediately preceding focus point when compared to the treatment beam to meet the desired point spread function beam width. Fig. 19 shows an embodiment of the treatment beam 286 spreading rapidly behind the focal point, and the width of the imaging beam 286 may need to be slightly larger to search for tissue or implants (e.g., bone, bowel) that do not readily couple ultrasound energy. In some embodiments, the goal is to better detect the acoustic window before the treatment focus and the tissue after the treatment focus to ensure safe and effective treatment.

Vector imaging

In some embodiments, beam pair coupling at the defocused acoustic window and after the treatment focus and testing of potential tissue disorders (e.g., bone, bowel) or implants are advantageous. The processing and display of this information can be used by the system operator to make appropriate decisions without interfering with normal imaging. In one embodiment, to provide information in a timely manner, transmit-receive events with defocused beams are interleaved with standard imaging. This form of imaging enables frame rates for conventional B-mode imaging and coupled pulses.

Fig. 20 shows an embodiment of the temporal progression of transmit-receive vectors for normal B-mode imaging. In standard imaging, a transmit-receive event occurs when the circular array 285 is at a proper azimuthal position (e.g., P1). In one embodiment, the ultrasound imaging and therapy system generates high resolution frames using 1 to 4 transmit focal points per imaging vector. Fig. 20 represents the position vector with "P" and then numbers. In one embodiment, P1 has three transmissions: TR1, TR2 and TR 3. DF1 is a query pulse to check whether the system is properly coupled to the tissue to be treated. In one embodiment, for 25mm, the scan would consist of 501 vectors separated by 0.050mm for a total imaging width of 25 mm. The transmit-receive event is represented by a "TR" and then a number. Fig. 20 shows that three transmit-receive events are associated with each location, or in other words, that there are three transmit foci for each vector location. In applying a defocused beam, it is not necessary to transmit at every location. This is because the beam has a beam width much greater than the sample spacing of 0.050 mm. Further, in one embodiment, the imaging beam width at the acoustic window for defocused transmission is approximately 5mm, and then possibly the window is sampled every 0.5 mm. Since there is virtually no additional information obtained from the finer samples. Such imaging involves an interleaved (e.g., overlapping, etc.) imaging method as shown in fig. 21.

Vector imaging is similar in fig. 21 to fig. 20, except that at P1 and then every 10 positions, a defocus vector is acquired. Thus, there are still 501 vectors acquired for the high resolution image. However, in addition to these 501 vectors, 51 vectors were acquired using defocused transmission to assess coupling at the acoustic window. The 501 vectors and corresponding transmit-receive events are treated differently than the 51 vectors used to assess coupling. Note that this is only one method of vector ordering. Since high resolution imaging is oversampled in the lateral direction by approximately four to five beam widths, it is possible to step down one sequence at one location and perform only defocused imaging. Averaging may be applied in case defocused imaging is applied to interpolate between vectors. This would permit shallow (e.g., at the acoustic window) and deep assessment (e.g., behind the focus) of coupling and tissue to assess the safety and efficacy of the therapeutic energy delivery. The type of ordering is similar to duplex imaging where B-mode and Doppler (Doppler) imaging are performed simultaneously.

In embodiments where there is sufficient transmit sensitivity and receive signal-to-noise ratio, synthetic transmit and receive aperture imaging may be used to achieve the best resolution in the ultrasound image and permit sufficient means to determine if there is sufficient coupling for the therapy transducer. Fig. 21 illustrates an embodiment in which defocused transmit-receive events are interleaved with three standard defocused transmit-receive events. This approach may cause a compromise with the resolution of the ultrasound image. In one embodiment, illustrated at fig. 22, the method transmits on each imaging array element separately and receives on separate receive elements. After digitizing and storing the data for each of the eight transmit receive sequences as shown in the timing diagram, the synthetic transmit and receive aperture method is used to generate the best resolution for the ultrasound images and develop the ideal beamwidth to assess the coupling of the therapy transducer. The synthetic transmit and receive aperture method applies both transmit and receive delays to the post-processed data for each spatial point in the ultrasound image simultaneously. This technique produces the desired resolution throughout the entire ultrasound image when there is sufficient received SNR at the expense of reduced frame rate. This same method can be applied when interrogating the treatment beam cross-section.

Image processing

In one embodiment, the use of a defocused beam has the advantage of helping the operator assess the tissue behind the coupling and acoustic focus. In one embodiment, a method of displaying information comprises the steps of: the change in brightness across the top of the image is calculated. A significant brightness change away from the dermis strongly suggests insufficient coupling, while a uniform brightness suggests uniform coupling across a large portion of the treatment beam. The intensity variation calculation will be the second moment of speckle intensity at a particular depth, such as 1mm to 2mm from the acoustic window.

In one embodiment, a two-dimensional (2D) filter function is used to reduce the brightness variations that naturally occur from speckle. In one embodiment, a quantitative or qualitative variable is presented to the user along with the high resolution image to suggest the quality of the coupling at the tissue behind the acoustic window or focus.

In one embodiment, the coupling assessment image is combined with the high resolution image. For example, two images may be multiplied together. This will provide an image to the operator without removing any information from the high resolution image. The 2D multiplication (pixel by pixel) will show the shadow from the differential coupling on top of the high resolution image. The operator can then decide whether the treatment is appropriate based on the amount of brightness shading. In one embodiment, the two images are blended together like an overlay, which permits greater emphasis on either the high resolution image or the coupling assessment image. In one embodiment, when combining registered images from different systems (e.g., MRI and ultrasound), the overlapping images may be configured in the same manner as the images presented to the radiologist.

Multiple focal zone sequencing

In various embodiments, ultrasound imaging is used in conjunction with therapeutic tissue treatment. According to various embodiments, an ultrasound treatment system generates one, two or more simultaneous therapeutic treatment points and/or focal zones under the skin surface for cosmetic treatment. In one embodiment, the treatment comprises mechanical flutter, wherein the treatment transducer moves locally around the expected center of the hot freezing point (TCP). The beam movement may be side-by-side, up and down and/or angular. In one embodiment of mechanical flutter, the movement of the motion mechanism is fast enough to produce a flatter temperature profile around the intended TCP, which allows for a reduction in total acoustic energy for the same affected tissue volume or allows for the same total acoustic energy for a more affected tissue volume or any combination thereof. According to various embodiments, the frequency modulation modifies the position of the focal zones and/or the spacing between the focal zones such that the electronic dithering of the beam via the frequency modulation precisely changes and/or moves the position of the beam focus. For example, in one embodiment, a small frequency swing may be used to dither at +/-0.1mm intervals of 1.5 mm. In various embodiments, the frequency swing may be used at any one or more of +/-0.01, 0.05, 0.1, 0.12, 0.15, 0.20, 0.25, 0.30mm dither 0.5, 0.75, 1.0, 1.2, 1.5, 2.0mm intervals. In various embodiments, the frequency may be modulated by 1% to 200% (e.g., 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 100%, 120%, 150%, 180%, 200%, and any range within).

In various embodiments for improved ultrasound imaging, multiple focal zones are employed to achieve better signal quality and resolution through depth. For conventional diagnostic ultrasound scanners (linear, curvilinear, phased arrays, etc.) that form 2D ultrasound images without having to move the transducer, the order in which the focal zones are acquired is less critical because the precise placement of the multiple focal zones can be electronically controlled. FIG. 23 illustrates focal band imaging with an electronically steered/translated aperture that does not move while imaging. For non-moving imaging transducers, the focal bands are positioned accurately, and therefore focal band sequencing is not employed. In a conventional multiple focal zone imaging sequence, the order of the focal zone queries varies. For example, a 4-focal-zone sequence will follow a series of numbers (f1, f2, f3, f4) independent of the position and direction of motion.

However, for a moving imaging transducer (e.g., mechanically translated or steered array), this becomes problematic due to the positional differences of the transducer as it scans across multiple focal zones. This positional misregistration is particularly magnified when imaging is formed bi-directionally (forming both left-to-right and right-to-left images), since the query region will be different between the two images. Fig. 24 demonstrates this principle in a linear translation environment, but the present disclosure is applicable to all types of motion, including but not limited to translation, rotation, and two dimensions or any combination thereof.

Embodiments of the imaging system disclosed herein address these misalignments. Fig. 24 illustrates bidirectional imaging at the same lateral position. In some cases, spatial misregistration occurs due to the fact that the transducer is moving while imaging. In particular, the focal zone 4(Fz4) may be considered to be spaced furthest apart between the two images, but they should query the same region of interest. When forming 2D images with a mechanically translated/steered transducer, the transmit/receive position of the transducer will change due to the fact that: the transducer has also moved during the travel time associated with the ultrasonic signal.

In one embodiment, an alternative sequence is proposed such that the first direction travel (outward) sequence will advance in order (f1, f2, f3, f4) while the second direction travel (return sequence) is opposite (f4, f3, f2, f1), allowing better registration of the two images. In one embodiment, an alternative sequence is proposed such that the right-going (outward) sequence should advance in order (f1, f2, f3, f4) and the left-going (return sequence) opposite (f4, f3, f2, f1), allowing better registration of the two images (fig. 25). In various embodiments, the direction may be left, right, forward, backward, upward, or downward.

FIG. 25 illustrates an embodiment of direction dependent focal band ordering. The left-going sequence is in reverse order with respect to the right-going sequence. Thus, the focal band alignment is improved. Further, the acquired positions may be staggered so that the same region of interest is better registered between the two images (fig. 26).

FIG. 26 illustrates an embodiment of direction dependent focal zone sequencing with different trigger positions. Spatial registration between right-and left-going a-lines has been further improved by staggering the trigger positions.

In an embodiment, the imaging system employs a novel sequence of two consecutive A lines that follow a series of numbers (lines 1: f1, f2, f3, f 4; lines 2: f4, f3, f2, f1) in succession. The sequence may be repeated across the entire field of view, and assuming an even number of vectors within the field of view, the return sequence may have exactly the same alternating pattern focal band sequence, and the two images will be registered (fig. 27).

FIG. 27 illustrates an embodiment of alternating direction dependent focal band ordering between (fl-f2-f3-f4) and (f4-f3-f2-fl) on consecutive A lines. If the entire field of view is scanned by an even number of A-lines, the focusing sequences for left and right progression are the same. The trigger position still varies between the two images.

In various embodiments, multi-focal-zone imaging provides the advantage of better correlation between images formed for first direction travel and second direction travel.

In various embodiments, multi-focal-zone imaging provides the advantage of increased effectiveness for B-mode imaging at faster (e.g., 2x, 3x, 4x) scan rates.

In various embodiments, multi-focal zone imaging is applicable to any number of focal zones greater than one. In various embodiments, the number of focal zones is two, three, four, five, six, seven, eight, nine, ten, or more.

Energy converter

In various embodiments, transducer 280 includes a convex surface 282 and a concave surface 283. In various embodiments, transducer 280 includes a convex surface 282 and a concave surface 283 having features that provide any one or more of variable depth, variable spacing, variable focal point positioning with one, two, three, four, or more simultaneous focal zones. FIG. 28 illustrates an embodiment of a transducer 280 comprising a single element having a convex surface 282 and a concave surface 283. Fig. 29 illustrates an embodiment of a transducer 280 comprising a solid, coated convex surface 282 and a striped concave surface 283, wherein the stripes comprise a first polarized and a second polarized region, wherein the polarized regions are positive, negative, or unpolarized. Fig. 29 illustrates an embodiment of a transducer 280 comprising a solid, coated convex surface 282 and a striped concave surface 283, wherein the stripes comprise a first region and a second region, wherein the regions may or may not comprise a coating.

Fig. 30 illustrates an embodiment of a transducer 280 comprising a striped convex surface 282 and a solid, coated concave surface 283, wherein the stripes comprise a first polarized and a second polarized region, wherein the polarized regions are positive, negative, or unpolarized. Fig. 30 illustrates an embodiment of a transducer 280 comprising a striped convex surface 282 and a solid, coated concave surface 283, wherein the stripes comprise a first region and a second region, wherein the regions may or may not comprise a coating.

Fig. 31 illustrates an embodiment of a transducer 280 comprising a striped convex surface 282 and a striped concave surface 283, wherein the stripes comprise first polarized and second polarized regions, wherein the polarized regions are either positive, negative, or unpolarized, wherein the striped regions are azimuthally rotated approximately 90 degrees with respect to each other. Fig. 31 illustrates an embodiment of a transducer 280 comprising a striped convex surface 282 and a solid, coated concave surface 283, wherein the stripes comprise a first region and a second region, wherein the regions may or may not comprise a coating, and wherein the stripes are rotated about 90 degrees relative to each other.

FIG. 32 illustrates an embodiment of a transducer 280 comprising an annular convex surface 282 and a striped concave surface 283, wherein the stripes comprise a first polarized and a second polarized region, wherein the polarized regions are positive, negative, or unpolarized. FIG. 32 illustrates an embodiment of a transducer 280 comprising an annular convex surface 282 and a striped concave surface 283, wherein the stripes comprise a first region and a second region, wherein the regions may or may not comprise a coating.

FIG. 33 illustrates an embodiment of a transducer 280 comprising a striped convex surface 282 and an annular concave surface 283, wherein the stripes comprise a first polarized and a second polarized region, wherein the polarized regions are positive, negative, or unpolarized. FIG. 33 illustrates an embodiment of a transducer 280 including a striped convex surface 282 and an annular concave surface 283, wherein the stripes include a first region and a second region, wherein the regions may or may not include a coating. In some implementations, a system includes various features that are present as a single feature (as opposed to multiple features). For example, in one embodiment, the system comprises, consists essentially of, or consists of a single ultrasound transducing element adapted to provide two simultaneous therapeutic zones via dithering. In alternative embodiments, a plurality of features or components are provided.

Some of the embodiments and examples described herein are examples and are not intended to be limiting in describing the full scope of the compositions and methods of these inventions. Equivalent changes, modifications and variations of some embodiments, materials, compositions and methods may be made within the scope of the present invention with substantially similar results.

While the invention is susceptible to various modifications and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the various embodiments described and the appended claims. Any methods disclosed herein need not be performed in the order listed. The methods disclosed herein include specific actions taken by a medical practitioner; however, they may also include any third party instruction explicitly or implicitly to the effect that these actions are included. For example, actions such as "coupling the transducer module with the ultrasound probe" include "indicating the coupling of the transducer module with the ultrasound probe". The ranges disclosed herein also encompass any and all overlaps, sub-ranges, and combinations thereof. Language such as "up to," "at least," "greater than," "less than," "between … …," and the like, includes the recited number. Numbers preceded by terms such as "about" or "approximately" include the recited numbers. For example, "about 25 mm" includes "25 mm".

Claims

1. An ultrasound therapy and imaging system configured to reduce imaging misalignment, the ultrasound therapy and imaging system comprising:

an ultrasound probe, comprising: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image the tissue; and a motion mechanism for moving the ultrasound imaging transducer in a first direction and a second direction,

wherein the ultrasound imaging transducer is mechanically attached to the motion mechanism,

wherein the first direction is opposite to the second direction,

wherein the ultrasonic imaging transducer is sequenced in a sequence of focal zones (f) while traveling in the first direction₁,...,f_N) Imaging, wherein N>1，

Wherein the ultrasound imaging transducer is sequenced in a second focal zone sequence (f) while traveling in the second direction_N,...,f₁) The image is formed by imaging the image,

wherein spatial registration between the first direction imaging and the second direction imaging is improved by staggering the trigger positions,

wherein the ultrasound therapy and imaging system employs (f) on a continuous A line₁-...-f_N) And (f)_N-...-f₁) Alternating directionally dependent focal zone ordering therebetween; and

a control module coupled to the ultrasound probe for controlling the ultrasound imaging transducer.

2. The ultrasound therapy and imaging system of claim 1, wherein the first direction of motion of the transducer is any one or more of the group consisting of: linear, rotational, and curved; wherein the second direction is a reverse path of the first direction.

3. The ultrasound therapy and imaging system of claim 1, wherein the first direction of motion occurs over multiple dimensions and the second direction is a reverse path of the first direction.

4. The ultrasound therapy and imaging system of claim 1, wherein the ultrasound imaging transducer is designated as (f)₁,...,f_N) Sequentially imaging the first focal zone sequence of (1), wherein N>2。

5. The ultrasound therapy and imaging system of claim 1, wherein the ultrasound therapy transducer is configured to treat tissue at a first set of locations positioned within a first cosmetic therapy band and a second set of locations positioned within a second cosmetic therapy band, the first band being different from the second band.

6. The ultrasound therapy and imaging system of any one of claims 1 to 5, wherein the ultrasound therapy transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

7. The ultrasound therapy and imaging system of claim 6, wherein at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more acoustic intensity amplitudes, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezoelectric varies over time.

8. The ultrasound therapy and imaging system of claim 6, wherein the ultrasound transducer comprises a piezoelectric material, and the portions of the ultrasound transducer are adapted to produce a plurality of corresponding piezoelectric material changes in response to an electric field applied to the ultrasound transducer.

9. The ultrasound therapy and imaging system of claim 8, wherein the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material.

10. The ultrasound therapy and imaging system of any one of claims 1 to 5, wherein the ultrasound transducer is adapted to apply ultrasound therapy via a phase shift, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity phases, wherein a first phase is different from a second phase.

11. The ultrasound therapy and imaging system of claim 10, wherein the plurality of phases comprise discrete phase values.

12. The ultrasound therapy and imaging system of any one of claims 1 to 5, wherein the ultrasound transducer is adapted to:

applying ultrasound therapy using amplitude modulation, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy at a plurality of acoustic intensity amplitudes, wherein a first amplitude is different from a second amplitude; and is

Applying ultrasound therapy, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity phases, wherein the first phase is different from the second phase.

13. The ultrasound therapy and imaging system of any one of claims 1 to 5, wherein the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder exposure improvement, hip lifting, scar reduction, burn treatment, skin tightening, blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, cellulite treatment, vaginal rejuvenation, and acne treatment.

14. The ultrasound therapy and imaging system of any one of claims 1 to 5, wherein the ultrasound therapy is a treatment for abdominal relaxation.

15. The ultrasound therapy and imaging system of any one of claims 1 to 5, wherein the ultrasound imaging transducer images sequentially with the first focal zone sequence designated as (f 1., fN), where N > 3.

16. The ultrasound therapy and imaging system of any one of claims 1 to 5, wherein the ultrasound imaging transducer images sequentially with the first focal zone sequence designated as (f 1.

17. The ultrasound therapy and imaging system of any one of claims 1 to 5, wherein the ultrasound imaging transducer images sequentially with the first focal zone sequence designated as (f 1.., fN), where N-10.

18. A method of using the system of any of claims 1-5, the method comprising: staggering trigger positions of spatial registration between first and second directional imaging of the ultrasound probe.

19. The method of claim 18, wherein N ═ is any one of the group consisting of: 2. 3, 4, 5, 6, 7, 8, 9 and 10.

20. The method of claim 18, wherein N-2.

21. The method of claim 18, wherein N-4.

22. The method of claim 18, wherein N-6.

23. The method of claim 18, wherein N-8.

24. The method of any one of claims 18 to 23, wherein the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder area improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening, vein removal, vein reduction, treatment of sweat glands, hyperhidrosis treatment, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

25. The method of any one of claims 18 to 23, wherein the ultrasound treatment is a treatment of abdominal relaxation.

26. Use of a system according to any one of claims 1 to 5 for tightening the skin.

27. Use of the system according to any one of claims 1 to 5 for raising eyebrows.

28. Use of a system according to any one of claims 1 to 5 for lifting loose tissue.

29. Use of a system according to any of claims 1 to 5 for lifting loose submental and neck tissue.

30. Use of a system according to any one of claims 1 to 5 for improving lines and wrinkles in a low neck exposed shoulder.

31. Use of a system according to any one of claims 1 to 5 for reducing fat.

32. Use of a system according to any one of claims 1 to 5 for reducing the appearance of cellulite.

33. Use of a system according to any of claims 1 to 5 for: ultrasound is focused to produce local mechanical motion within tissues and cells for the purpose of producing local heating or mechanical cell membrane disruption intended for non-invasive aesthetic use of tissue coagulation.

34. A method of reducing imaging misalignment in a moving ultrasound probe, the method comprising the steps of:

staggering trigger positions of spatial registration between first direction imaging and second direction imaging of the ultrasound probe,

the ultrasonic probe includes: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image the tissue; and a motion mechanism for moving the ultrasound imaging transducer in a first direction and a second direction,

wherein the first direction is opposite to the second direction,

wherein the ultrasonic imaging transducer is sequenced in a first focal zone sequence (f) while traveling in the first direction₁,...,f_N) Imaging, wherein N>2，

Wherein the ultrasound imaging transducer is sequenced in a second focal zone sequence (f) while traveling in the second direction_N,...,f₁) And (6) imaging.

35. The method of claim 34, wherein N ═ is any one of the group consisting of: 3. 4, 5, 6, 7, 8, 9 and 10.

36. The method of claim 18, wherein N-4.

37. The method of claim 18, wherein N-5.

38. The method of claim 18, wherein N-7.

39. The method of any one of claims 18 to 38, wherein the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder area improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening, vein removal, vein reduction, treatment of sweat glands, hyperhidrosis treatment, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

40. A method according to any one of claims 18 to 38, wherein the ultrasound treatment is treatment of abdominal relaxation.

41. An ultrasound therapy system for dithering multiple simultaneous focal points from an ultrasound transducer, the ultrasound therapy system comprising:

an ultrasound probe comprising an ultrasound transducer having a single transducing element adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations of a focal depth,

wherein the ultrasonic transducer is polarized with at least a first polarization configuration and a second polarization configuration,

a control module coupled to the ultrasound probe for controlling the ultrasound transducer,

wherein the control module modifies the separation between the spaced locations via dithering of the first and second focal bands such that the dithering via frequency modulation precisely moves the location of the beam focus at the spaced locations.

42. The treatment system of claim 41, wherein the plurality of locations are positioned within a cosmetic treatment band in a linear sequence, wherein the spaced locations are separated by an interval that oscillates via a frequency oscillation.

43. The treatment system of claim 41, wherein a first set of locations are positioned within a first cosmetic treatment band and a second set of locations are positioned within a second cosmetic treatment band, the first band being different from the second band.

44. The therapeutic system of claim 41 wherein the ultrasound transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy at a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

45. The therapy system of claim 44, wherein at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more acoustic intensity amplitudes, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezos varies over time.

46. A therapeutic system according to claim 44, wherein the ultrasound transducer comprises a piezoelectric material and the portions of the ultrasound transducer are adapted to produce a plurality of corresponding piezoelectric material changes in response to an electric field applied to the ultrasound transducer.

47. The treatment system of claim 46, wherein the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material.

48. The therapeutic system of any one of claims 41 to 44, wherein the ultrasound transducer is adapted to apply ultrasound therapy via phase shifting, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity phases, wherein a first phase is different from a second phase.

49. The therapeutic system of claim 48, wherein the plurality of phases comprises discrete phase values.

50. The therapeutic system of any one of claims 41 to 44, wherein the ultrasound transducer is adapted to:

51. The therapy system of any of claims 41-44, wherein the ultrasound therapy is at least one of: removing wrinkles from face, eyebrows, chin, eye, wrinkle, improving low neck and shoulder, hip, scar, burn, skin tightness, blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, and cellulite treatment.

52. A therapeutic system according to any one of claims 41 to 44 wherein the ultrasound treatment is treatment of abdominal relaxation.

53. The therapeutic system of any one of claims 41 to 44, wherein the ultrasound probe comprises a motion mechanism adapted to direct ultrasound therapy in at least one pair of simultaneous sequences of independent thermal cosmetic treatment zones.

54. The system of any of claims 41 to 44, wherein the ultrasound probe is configured to perform ultrasound imaging and ultrasound therapy.

55. A therapeutic system according to any one of claims 41 to 44, wherein the ultrasound probe includes a transducer module adapted to apply ultrasound therapy.

56. An ultrasound therapy system for dithering multiple simultaneous focal points from an ultrasound transducer for cosmetic treatment, the system comprising:

an ultrasound probe, comprising:

a control module adapted to modify a spacing between the first focal zone and the second focal zone via dithering, a switch operable to control an ultrasound therapy function for providing ultrasound therapy;

a motion mechanism adapted to direct ultrasound therapy in at least one pair of simultaneous sequences of independent thermal cosmetic treatment zones; and

a transducer module adapted to apply ultrasound therapy,

wherein the transducer module is adapted for ultrasound imaging and ultrasound therapy,

wherein the transducer module is adapted to be coupled to the ultrasound probe,

wherein the transducer module comprises an ultrasound transducer adapted to apply ultrasound therapy to tissue at a plurality of locations of a focal depth,

wherein the transducer module is adapted to be operably coupled to at least one of the switch and the motion mechanism; and is

Wherein the control module comprises a processor and a display for controlling the transducer module.

57. The therapy system of claim 56, wherein the transducer module is adapted to apply ultrasound therapy using amplitude modulation, whereby portions of the transducer module are adapted to transmit ultrasound therapy at a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

58. The therapeutic system of any one of claims 56 to 57 wherein the transducer module is adapted to apply ultrasound therapy, whereby portions of the transducer module are adapted to transmit ultrasound therapy in a plurality of acoustic intensity phases, wherein a first phase is different from a second phase.

59. An ultrasound therapy system for fluttering multifocal therapy, the ultrasound therapy system comprising:

a module comprising an ultrasound transducer is provided,

wherein the ultrasound transducer is adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations in the tissue,

wherein the module modifies the spacing between the plurality of spaced locations via dithering of the first and second focal bands such that the dithering via frequency modulation precisely moves the position of the beam focus at the plurality of spaced locations,

wherein the module further comprises a connector guide designed for removably coupling to a hand wand to provide electronic communication and power between the module and the hand wand.

60. The therapeutic system of claim 59 wherein the ultrasound transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy at a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

61. The therapeutic system of claim 59 wherein the ultrasound transducer is adapted to apply ultrasound therapy, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy in a plurality of acoustic intensity phases, wherein the first phase is different from the second phase.

62. The therapeutic system of claim 59 wherein the ultrasound transducer comprises a piezoelectric material and the portions of the ultrasound transducer are adapted to produce a plurality of corresponding changes in the piezoelectric material in response to an electric field applied to the ultrasound transducer.

63. The therapeutic system of claim 59, wherein at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more acoustic intensity amplitudes, and wherein the amplitude of ultrasound therapy emitted by the at least a portion of the ultrasound transducer remains constant over time.

64. The therapy system of any of claims 59-63, wherein the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder area improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening, vein removal, vein reduction, treatment of sweat glands, hyperhidrosis treatment, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

65. A therapeutic system according to any one of claims 59 to 63 wherein the ultrasound treatment is treatment of abdominal relaxation.

66. A method of dithering a simultaneously focused ultrasound therapy beam, the method comprising the steps of:

providing an ultrasound probe comprising an ultrasound transducer comprising a single transducing element adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations of a focal depth, and a control module coupled to the ultrasound probe for controlling the ultrasound transducer; and

dithering the separation between the spaced locations of the first and second focal zones via frequency modulation to move a location of an ultrasound focus point at the spaced locations.

67. The method of claim 66, further comprising the steps of: imaging the first focal zone with an ultrasound imaging element.

68. The method of claim 66, further comprising the steps of: imaging the second focal zone with an ultrasound imaging element.

69. The method of claim 66, wherein the separation between the first focal zone and the second focal zone is dithered in a range between 1% and 50%.

70. The method of claim 66, wherein the separation between the first focal zone and the second focal zone is 1.5mm and differs by 0.1 mm.

71. The method of claim 66, wherein the frequency modulation is in a range between 1% and 50%.

72. The method of any one of claims 66 to 71, wherein the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder area improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening, vein removal, vein reduction, treatment of sweat glands, hyperhidrosis treatment, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

73. A method according to any one of claims 66 to 71 wherein the ultrasound treatment is treatment of abdominal relaxation.

74. A method of dithering a focused ultrasound beam, the method comprising the steps of:

an ultrasound probe comprising a single transducing element and a control module are provided,

wherein the single transducing element is adapted to apply ultrasound therapy to tissue at a focal zone of a focal depth,

wherein the control module is coupled to the ultrasound probe for controlling the single transducing element; and

dithering the focal zone via frequency modulation to change a size of the focal zone at the tissue.

75. The method of claim 74, wherein the relative position of the focal zones flutters in a range between 1% and 50%.

76. The method of claim 74, wherein a second focal zone is simultaneously emitted from the single transducing element.

77. The method of claim 74, further comprising the steps of: the focal zone is imaged with an ultrasound imaging element.

78. The method of claim 74, wherein the frequency modulation is in a range between 1% and 50%.

79. The treatment system of claim 74, wherein the system is designed to work non-invasively to treat tissue.

80. The method of any one of claims 74-78, wherein the method functions in a non-invasive manner to treat tissue.

81. An ultrasound therapy system configured to generate a plurality of simultaneous focal points from an ultrasound transducer, the ultrasound therapy system comprising:

an ultrasound probe comprising an ultrasound transducer having a plurality of transducing elements adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations,

wherein each transducing element includes a channel in which the ultrasound probe has a geometric focus;

wherein the ultrasound probe has a first electron focus; and is

Wherein the ultrasound probe has a second electron focus;

wherein the control module modifies the separation between the spaced locations via dithering of the first and second focal bands such that dithering via the excitation function moves the location of the beam focus at the spaced locations.

82. The treatment system of claim 81, wherein the plurality of locations are positioned within a cosmetic treatment band in a linear sequence, wherein the spaced locations are separated.

83. The treatment system of claim 81, wherein a first set of locations are positioned within a first cosmetic treatment band and a second set of locations are positioned within a second cosmetic treatment band, the first band being different from the second band.

84. The therapeutic system of claim 81, wherein the ultrasound transducer is adapted to apply ultrasound therapy, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy at a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

85. The therapy system of claim 84, wherein at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more acoustic intensity amplitudes, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezos varies over time.

86. The therapeutic system of claim 84 wherein the ultrasound transducer comprises a piezoelectric material and the portions of the ultrasound transducer are adapted to produce a plurality of corresponding piezoelectric material changes in response to an electric field applied to the ultrasound transducer.

87. The treatment system of claim 86, wherein the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material.

88. The therapeutic system of any one of claims 81 to 87, wherein the ultrasound transducer is adapted to apply ultrasound therapy via phase shifting, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity phases, wherein a first phase is different from a second phase.

89. The therapeutic system of claim 88, wherein the plurality of phases comprises discrete phase values.

90. The therapy system of any one of claims 81-87, wherein the ultrasound transducer is adapted to:

91. The therapy system of any of claims 81-87, wherein the ultrasound therapy is at least one of: removing wrinkles from face, eyebrows, chin, eye, wrinkle, improving low neck and shoulder, hip, scar, burn, skin tightness, blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, and cellulite treatment.

92. The system of any of claims 81-87, wherein the ultrasound therapy is a treatment for abdominal relaxation.

93. An ultrasound therapy system for forming multiple simultaneous focal zones from an ultrasound transducer for cosmetic therapy, the system comprising:

an ultrasound probe, comprising:

a control module adapted to modify a spacing between the first focal zone and the second focal zone;

a switch operable to control an ultrasound therapy function for providing ultrasound therapy;

a transducer module adapted to apply ultrasound therapy,

wherein the transducer module is adapted for ultrasound imaging and/or ultrasound therapy,

wherein the transducer module is adapted to be coupled to the ultrasound probe,

wherein the transducer module comprises an ultrasound transducer adapted to simultaneously apply ultrasound therapy to tissue at a plurality of locations,

94. The system of claim 93, wherein the transducer module is adapted to apply ultrasound therapy, whereby portions of the transducer module are adapted to transmit ultrasound therapy at a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

95. The therapeutic system of claim 93, wherein the transducer module is adapted to apply ultrasound therapy, whereby portions of the transducer module are adapted to emit ultrasound therapy at a plurality of acoustic intensities.

96. An ultrasound therapy system for generating multi-focal therapy using multi-channel signal mixing, the ultrasound therapy system comprising:

a module comprising an ultrasound transducer is provided,

wherein the ultrasound transducer is adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations in the tissue, wherein the module modifies a spacing between the plurality of spaced apart locations between the first focal zone and the second focal zone such that the multi-channel signal mixing precisely moves a position of the beam focus at the plurality of spaced apart locations,

97. The system of claim 96, wherein the ultrasound transducer is adapted to apply ultrasound therapy, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy at a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

98. The therapeutic system of claim 96 wherein the ultrasound transducer is adapted to apply ultrasound therapy, whereby portions of the ultrasound transducer are adapted to transmit ultrasound therapy in a plurality of acoustic intensity phases, wherein a first phase is different from a second phase.

99. The therapeutic system of claim 96, wherein the ultrasound transducer comprises a piezoelectric material and the portions of the ultrasound transducer are adapted to produce a plurality of corresponding piezoelectric material changes in response to an electric field applied to the ultrasound transducer.

100. The therapeutic system of claim 96, wherein at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more acoustic intensity amplitudes, and wherein the amplitude of ultrasound therapy emitted by at least a portion of the ultrasound transducer remains constant over time.

101. The therapy system of any of claims 96-100, wherein the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder area improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening, vein removal, vein reduction, treatment of sweat glands, hyperhidrosis treatment, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

102. The system of any of claims 96-100, wherein the ultrasound therapy is a treatment for abdominal relaxation.

103. A method of generating simultaneously focused ultrasound therapy beams using multi-channel signal mixing, the method comprising the steps of:

providing an ultrasound probe comprising an ultrasound transducer comprising a plurality of transducing elements adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations at a plurality of focal depths and a control module coupled to the ultrasound probe for controlling the ultrasound transducer; and

modifying the separation between the spaced locations of the first and second focal zones via multi-channel signal mixing to move the location of the ultrasound focus point at the spaced locations.

104. The method of claim 103, further comprising the steps of: imaging the first focal zone with an ultrasound imaging element.

105. The method of claim 103, further comprising the steps of: imaging the second focal zone with an ultrasound imaging element.

106. The method of claim 103, wherein the separation between the first focal zone and the second focal zone varies in a range between 1% and 50%.

107. The method of claim 103, wherein the separation between the first focal zone and the second focal zone is 1.5mm and differs by 0.1 mm.

108. The method of claim 103, wherein a spacing between electron foci is in a range between 10% and 50% of a nominal distance between said electron foci.

109. The method of any one of claims 103 to 108, wherein the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder area improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening, vein removal, vein reduction, treatment of sweat glands, hyperhidrosis treatment, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

110. The method of any one of claims 103 to 108, wherein the ultrasound treatment is a treatment of abdominal relaxation.

111. A method of generating simultaneously focused ultrasound beams, the method comprising the steps of:

an ultrasound probe comprising an array of transducing elements and a control module are provided,

wherein the array of transducing elements is adapted to apply ultrasound therapy to tissue at a focal zone at a plurality of focal points,

wherein the control module is coupled to the ultrasound probe for controlling the array of transducing elements; and

moving the focal zone.

112. The method of claim 111, wherein the relative position of the focal bands is moved within a range between 10% and 50%.

113. The method of claim 111, wherein the second focal zone is simultaneously emitted from a single transducing element.

114. The method of claim 111, further comprising the steps of: the focal zone is imaged with an ultrasound imaging element.

115. The treatment system according to any one of claims 81-102, wherein the system is designed to operate non-invasively to treat tissue.

116. The method of any one of claims 103-113, wherein the method functions in a non-invasive manner to treat tissue.

117. An ultrasound therapy and imaging system, comprising:

an ultrasound probe, comprising: an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue; an ultrasound imaging transducer adapted to image the tissue; and an acoustic window, and a sound window,

wherein the ultrasound imaging transducer comprises an annular imaging array;

wherein the ultrasound imaging transducer comprises a plurality of transmit channels;

wherein the ultrasound imaging transducer comprises a plurality of receive channels;

wherein the ultrasound imaging transducer is configured to focus at a location proximate the ultrasound imaging transducer with respect to a distance between the ultrasound imaging transducer and the acoustic window; and

a control module coupled to the ultrasound probe for controlling the ultrasound imaging transducer,

wherein the ultrasound imaging transducer is configured to interrogate more than 40% of the acoustic window.

118. The ultrasound therapy and imaging system of claim 117, wherein an imaging beam width from the ultrasound imaging transducer is at least 20% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

119. The ultrasound therapy and imaging system of claim 117, wherein an imaging beam width from the ultrasound imaging transducer is at least 30% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

120. The ultrasound therapy and imaging system of claim 117, wherein an imaging beam width from the ultrasound imaging transducer is at least 40% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

121. The ultrasound therapy and imaging system of claim 117, wherein an imaging beam width from the ultrasound imaging transducer is at least 50% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

122. The ultrasound therapy and imaging system of claim 117, wherein an imaging beam width from the ultrasound imaging transducer is at least 80% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

123. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the coupling of imaging by the ultrasound imaging transducer provides an indication of coupling for therapy by the ultrasound therapy transducer.

124. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the ultrasound imaging transducer is configured to interrogate more than 80% of the acoustic window.

125. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the ultrasound imaging transducer is configured to interrogate more than 90% of the acoustic window.

126. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the annular imaging array is positioned in the ultrasound therapy transducer.

127. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the control module controls the ultrasound imaging transducer for vector imaging.

128. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the control module controls the ultrasound imaging transducer to perform defocus vector imaging.

129. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the ultrasound therapy transducer is configured to treat tissue at a first set of locations positioned within a first cosmetic treatment zone and a second set of locations positioned within a second cosmetic treatment zone, the first zone being different from the second zone.

130. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the ultrasound therapy transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

131. The ultrasound therapy and imaging system of claim 130, wherein at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more acoustic intensity amplitudes, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezoelectric varies over time.

132. The ultrasound therapy and imaging system of claim 130, wherein the ultrasound transducer comprises a piezoelectric material and the portions of the ultrasound transducer are adapted to produce a plurality of corresponding piezoelectric material changes in response to an electric field applied to the ultrasound transducer.

133. The ultrasound therapy and imaging system of claim 132, wherein the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material.

134. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the ultrasound transducer is adapted to apply ultrasound therapy via phase shifting, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity phases, wherein the first phase is different from the second phase.

135. The ultrasound therapy and imaging system of claim 134, wherein the plurality of phases comprise discrete phase values.

136. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the ultrasound transducer is adapted to:

137. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the ultrasound therapy is at least one of: removing wrinkles from face, eyebrows, chin, eye, wrinkle, improving low neck and shoulder, hip, scar, burn, skin tightness, blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, and cellulite treatment.

138. The ultrasound therapy and imaging system of any one of claims 117 to 122, wherein the ultrasound therapy is treatment of abdominal laxity.

139. An ultrasound therapy and imaging system, comprising:

wherein the ultrasound imaging transducer comprises an annular imaging array;

wherein the ultrasound imaging transducer operates at an imaging frequency between 8MHz and 50MHz,

wherein the ultrasound imaging transducer is configured to image tissue at a depth of up to 25mm below the skin surface;

wherein the ultrasound imaging transducer is configured to focus at a location behind the ultrasound imaging transducer with respect to the acoustic window; and

wherein the ultrasound imaging transducer is configured to interrogate more than 10% of the acoustic window.

140. The ultrasound therapy and imaging system of claim 139, wherein an imaging beam width from the ultrasound imaging transducer is at least 20% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

141. The ultrasound therapy and imaging system of claim 139, wherein an imaging beam width from the ultrasound imaging transducer is at least 30% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

142. The ultrasound therapy and imaging system of claim 139, wherein an imaging beam width from the ultrasound imaging transducer is at least 40% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

143. The ultrasound therapy and imaging system of claim 139, wherein an imaging beam width from the ultrasound imaging transducer is at least 50% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

144. The ultrasound therapy and imaging system of claim 139, wherein an imaging beam width from the ultrasound imaging transducer is at least 80% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

145. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the coupling of imaging by the ultrasound imaging transducer provides an indication of coupling for therapy by the ultrasound therapy transducer.

146. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the ultrasound imaging transducer is configured to interrogate more than 80% of the acoustic window.

147. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the ultrasound imaging transducer is configured to interrogate more than 90% of the acoustic window.

148. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the annular imaging array is positioned in the ultrasound therapy transducer.

149. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the control module controls the ultrasound imaging transducer for vector imaging.

150. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the control module controls the ultrasound imaging transducer to perform defocus vector imaging.

151. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the ultrasound therapy transducer is configured to treat tissue at a first set of locations positioned within a first cosmetic treatment zone and a second set of locations positioned within a second cosmetic treatment zone, the first zone being different from the second zone.

152. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the ultrasound therapy transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

153. The ultrasound therapy and imaging system of claim 152, wherein at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more acoustic intensity amplitudes, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezoelectric varies over time.

154. The ultrasound therapy and imaging system of claim 152, wherein the ultrasound transducer comprises a piezoelectric material and the portions of the ultrasound transducer are adapted to produce a plurality of corresponding piezoelectric material changes in response to an electric field applied to the ultrasound transducer.

155. The ultrasound therapy and imaging system of claim 154, wherein the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material.

156. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the ultrasound transducer is adapted to apply ultrasound therapy via phase shifting, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity phases, wherein the first phase is different from the second phase.

157. The ultrasound therapy and imaging system of claim 156, wherein the plurality of phases comprises discrete phase values.

158. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the ultrasound transducer is adapted to:

159. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the ultrasound therapy is at least one of: removing wrinkles from face, eyebrows, chin, eye, wrinkle, improving low neck and shoulder, hip, scar, burn, skin tightness, blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, and cellulite treatment.

160. The ultrasound therapy and imaging system of any one of claims 139 to 144, wherein the ultrasound therapy is treatment of abdominal laxity.

161. An ultrasound therapy and imaging system, comprising:

wherein the ultrasound imaging transducer comprises an annular or linear imaging array;

wherein the ultrasound imaging transducer is configured to interrogate more than 15% of the acoustic window.

162. The ultrasound therapy and imaging system of claim 161, wherein an imaging beam width from the ultrasound imaging transducer is at least 20% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

163. The ultrasound therapy and imaging system of claim 161, wherein an imaging beam width from the ultrasound imaging transducer is at least 30% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

164. The ultrasound therapy and imaging system of claim 161, wherein an imaging beam width from the ultrasound imaging transducer is at least 40% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

165. The ultrasound therapy and imaging system of claim 161, wherein an imaging beam width from the ultrasound imaging transducer is at least 50% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

166. The ultrasound therapy and imaging system of claim 161, wherein an imaging beam width from the ultrasound imaging transducer is at least 80% of a cross-sectional dimension of a treatment beam width from the ultrasound therapy transducer.

167. The ultrasound therapy and imaging system of any one of claims 161 to 166, wherein the coupling of imaging by the ultrasound imaging transducer provides an indication of coupling for therapy by the ultrasound therapy transducer.

168. The ultrasound therapy and imaging system of any one of claims 161 to 166, wherein the ultrasound imaging transducer is configured to interrogate more than 80% of the acoustic window.

169. The ultrasound therapy and imaging system of any one of claims 161 to 166, wherein the ultrasound imaging transducer is configured to interrogate more than 90% of the acoustic window.

170. The ultrasound therapy and imaging system of any one of claims 161 to 166, wherein the annular imaging array is positioned in the ultrasound therapy transducer.

171. The ultrasound therapy and imaging system of any one of claims 161-166, wherein the control module controls the ultrasound imaging transducer for vector imaging.

172. The ultrasound therapy and imaging system of any one of claims 161-166, wherein the control module controls the ultrasound imaging transducer to perform defocus vector imaging.

173. The ultrasound therapy and imaging system of any one of claims 161-166, wherein the ultrasound therapy transducer is configured to treat tissue at a first set of locations positioned within a first cosmetic treatment zone and a second set of locations positioned within a second cosmetic treatment zone, the first zone being different from the second zone.

174. The ultrasound therapy and imaging system of any one of claims 161 to 166, wherein the ultrasound therapy transducer is adapted to apply ultrasound therapy using amplitude modulation, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity amplitudes, wherein the first amplitude is different from the second amplitude.

175. The ultrasound therapy and imaging system of claim 174, wherein at least a portion of the ultrasound transducer is adapted to emit ultrasound therapy of two or more acoustic intensity amplitudes, and wherein the amplitude of the ultrasound therapy emitted by at least a portion of the piezoelectric varies over time.

176. The ultrasound therapy and imaging system of claim 174, wherein the ultrasound transducer comprises a piezoelectric material and the portions of the ultrasound transducer are adapted to produce a plurality of corresponding piezoelectric material changes in response to an electric field applied to the ultrasound transducer.

177. The ultrasound therapy and imaging system of claim 176, wherein the plurality of piezoelectric material changes includes at least one of an expansion of the piezoelectric material and a contraction of the piezoelectric material.

178. The ultrasound therapy and imaging system of any one of claims 161 to 177, wherein the ultrasound transducer is adapted to apply ultrasound therapy via phase shifting, whereby portions of the ultrasound transducer are adapted to emit ultrasound therapy of a plurality of acoustic intensity phases, wherein the first phase is different from the second phase.

179. The ultrasound therapy and imaging system of claim 178, wherein the plurality of phases comprise discrete phase values.

180. The ultrasound therapy and imaging system of any one of claims 161 to 179, wherein the ultrasound transducer is adapted to:

181. The ultrasound therapy and imaging system of any one of claims 161 to 180, wherein the ultrasound therapy is at least one of: removing wrinkles from face, eyebrows, chin, eye, wrinkle, improving low neck and shoulder, hip, scar, burn, skin tightness, blood vessel reduction, sweat gland treatment, freckle removal, fat treatment, and cellulite treatment.

182. The ultrasound therapy and imaging system of any one of claims 161 to 180, wherein the ultrasound therapy is treatment of abdominal laxity.

183. A method of confirming coupling between an ultrasound probe and tissue for treatment, the method comprising the steps of:

setting an ultrasonic probe and a control module, wherein the ultrasonic probe comprises an acoustic window; an ultrasound transducer comprising an ultrasound therapy transducing element adapted to apply ultrasound therapy to tissue; an array of a plurality of imaging transducing elements for imaging the tissue; the control module is coupled to the ultrasonic probe and used for controlling the ultrasonic transducer; and

interrogating at least 40% of the acoustic window with imaging beams from the plurality of imaging transducer elements.

184. The method of claim 183, wherein the plurality of imaging transducing elements interrogates at least 50% of the acoustic window.

185. The method of claim 183, wherein the plurality of imaging transducing elements interrogates at least 60% of the acoustic window.

186. The method of claim 183, wherein the plurality of imaging transducing elements interrogates at least 70% of the acoustic window.

187. The method of claim 183, wherein the plurality of imaging transducing elements interrogates at least 80% of the acoustic window.

188. The method of claim 183, wherein the plurality of imaging transducing elements interrogates at least 90% of the acoustic window.

189. The method of any one of claims 183-188, further comprising vector imaging.

190. The method of any of claims 183-188, further comprising defocus vector imaging.

191. The method of any one of claims 183-188, further comprising the step of: a first focal zone in the tissue is imaged with the plurality of imaging transducer elements.

192. The method of any one of claims 183-188, further comprising the step of: imaging a second focal zone in the tissue with the plurality of imaging transducer elements.

193. The method of any one of claims 183-188, wherein the ultrasound therapy is at least one of: facial wrinkle removal, eyebrow lifting, chin lifting, eye repair, wrinkle removal, low neck and shoulder area improvement, hip lifting, scar reduction, burn treatment, tattoo removal, skin tightening, vein removal, vein reduction, treatment of sweat glands, hyperhidrosis treatment, freckle removal, fat treatment, vaginal rejuvenation, and acne treatment.

194. The method of any one of claims 183 to 188, wherein the ultrasound treatment is a treatment of abdominal relaxation.

195. An ultrasound module configured to reduce imaging misalignment, the ultrasound module comprising:

an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue;

an ultrasound imaging transducer adapted to image the tissue; and

a motion mechanism for moving the ultrasound imaging transducer in a first direction and a second direction,

wherein the first direction is opposite to the second direction,

wherein the ultrasound module employs (f) on a continuous A line₁-...-f_N) And (f)_N-...-f₁) Alternate direction phase betweenThe focus band is ordered.

196. An ultrasound therapy module for dithering multiple simultaneous focal points, the ultrasound therapy module comprising:

an ultrasound transducer comprising a single transducing element adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations of a focal depth,

wherein the ultrasound transducer is configured to vary the separation between the spaced locations via dithering of the first and second focal bands such that the dithering via frequency modulation precisely moves the location of the beam focus at the spaced locations.

197. An ultrasound therapy module configured to generate a plurality of simultaneous focal points, the ultrasound therapy module comprising:

an ultrasound transducer having a plurality of transducing elements adapted to simultaneously apply ultrasound therapy to tissue at a plurality of spaced apart locations,

wherein each transducing element includes a channel in which the ultrasound module has a geometric focus;

wherein the ultrasound module has a first electronic focus; and is

Wherein the ultrasound module has a second electron focus;

wherein the ultrasound transducer is configured to modify the separation between the spaced locations via dithering of the first and second focal bands such that dithering via the excitation function moves the location of the beam focus at the spaced locations.

198. An ultrasound therapy and imaging module, comprising:

an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue;

an ultrasound imaging transducer adapted to image the tissue; and

the sound window is arranged on the base plate,

wherein the ultrasound imaging transducer comprises an annular imaging array;

wherein the ultrasound imaging transducer is configured to focus at a location proximate the ultrasound imaging transducer with respect to a distance between the ultrasound imaging transducer and the acoustic window;

199. An ultrasound therapy and imaging module, comprising:

an ultrasound therapy transducer adapted to apply ultrasound therapy to tissue;

an ultrasound imaging transducer adapted to image the tissue; and

the sound window is arranged on the base plate,

wherein the ultrasound imaging transducer comprises an annular imaging array;

wherein the ultrasound imaging transducer is configured to focus at a location behind the ultrasound imaging transducer with respect to the acoustic window;

200. An ultrasound therapy system having one or more of the features described in the foregoing description.

201. A method of reducing imaging misalignment in a moving ultrasound transducer, the method having one or more of the features described in the foregoing description.

202. An ultrasound therapy system for dithering multiple simultaneous foci from an ultrasound transducer, the ultrasound therapy system having one or more of the features described in the foregoing description.

203. An ultrasound therapy system for fluttering multifocal therapy having one or more of the features described in the foregoing description.

204. An ultrasound therapy module for forming a plurality of simultaneous focal zones from an ultrasound transducer for cosmetic treatment, the ultrasound therapy module having one or more of the features described in the foregoing description.

205. A method of generating simultaneously focused ultrasound therapy beams using multi-channel signal mixing, the method having one or more of the features described in the foregoing description.

206. A method of generating simultaneously focused ultrasound beams having one or more of the features set out in the preceding description.